2021 Volume 3 Issue 1 Article ID: ROEL2021
The Japan Society for Occupational Health (JSOH) recommends the Occupational Exposure Limits (OELs) as reference values for preventing adverse health effects on workers caused by occupational exposure to chemical substances, continuous or intermittent noise, impulsive or impact noise, heat stress, cold stress, whole-body vibration, hand-arm vibration and time-varying electric, magnetic and electromagnetic fields and ultraviolet and ionizing radiation.
1. OELs should be applied by individuals well-trained and experienced in occupational health.
2. OELs cannot be applied in cases where exposure duration or work intensity exceeds the prerequisite conditions for setting an OEL.
3. OELs are set based on various information obtained from experiences in industries and experiments on humans and animals. However, the quantity and quality of information used in setting OELs is not always the same.
4. Types of health effects considered in setting OELs depend on the substances involved; an explicit health impairment provides the basis for OELs in certain substances, while health effects such as discomfort, irritation or CNS suppressive effects afford the basis in others. Thus, OELs cannot be used simply as a relative scale of toxicity.
5. Due to the variance in individual susceptibilities, discomfort, deterioration of pre-existing ill health or occupational disease may be induced at levels of exposure below the OELs, even though the chances of this should be remote.
6. Because OELs do not represent a definitive borderline between safe and hazardous conditions, it is not correct to conclude that working environments above OEL are the direct and sole cause of health impairment in workers, or vice versa.
7. OELs cannot be applied as reference values in non-occupational environments.
8. OELs will be revised when JSOH considers it necessary.
9. JSOH welcomes the submission, by concerned parties or individuals, of opinions based on scientific aspects of OELs.
10. In the reproduction of any Tables and/or Figures of OELs, JSOH requires that the full text of OELs be quoted to prevent misunderstanding and misuse.
Exposure concentration is defined as the concentration of a chemical substance in air which will be inhaled by a worker during a job without the use of protective respiratory equipment.
Occupational Exposure Limit-Mean (OEL-M) for mean concentration of a chemical substance is defined as the reference value to the mean exposure concentration at or below which adverse health effects caused by the substance do not appear in most workers working for 8 hours a day, 40 hours a week under a moderate work-load. Exposure above OEL-M should be avoided even where duration is short or work intensity is light. If mean levels and duration of exposure corresponding to segments of various jobs can be measured or estimated, then an overall exposure concentration can be determined as the time-weighted average concentration.
Occupational Exposure Limit-Ceiling (OEL-C) of occupational exposure to a chemical substance is defined as the reference value to the maximal exposure concentration of the substance during a working day at or below which adverse health effects do not appear in most workers. The main reason why OEL-C is recommended for some substances is that the toxicity in question can induce immediate adverse effects such as irritation or CNS suppressive effects. However, it is quite difficult in practice to measure the momentary maximal exposure concentration. Short-term measurement lasting for 5 minutes or less at the time when the highest exposure concentration is expected may be used as a substitute for the measurement of maximal exposure concentration.
2. Variability of exposure concentrationExposure concentration fluctuates around the mean value. OEL-M should be referred to only when the fluctu-ation is not large. Allowable range of fluctuation depends on the substance. In practical terms, the mean exposure concentration for a period of 15 minutes during which maximum exposure concentration is expected should not exceed 1.5 times OEL-M, unless otherwise notified.
3. Skin absorption“S” marks in Tables I-1 and I-2 show that a significant dose from the view of systemic health effects or absorption of the substance concerned may be absorbed through the skin when the substance is in contact with the skin. OELs are set at conditions under which no skin absorption will take place.
Substance [CAS No.] | OEL | Skin absorption | Class of carcino- genicity | Class of sensitizing potential | Reproductive Toxicants | Year of proposal | ||
---|---|---|---|---|---|---|---|---|
ppm | mg/m3 | Airway | Skin | |||||
Acetaldehyde [75-07-0] | (Table I-2) | 2B | ʼ21 | |||||
Acetic acid [64-19-7] | 10 | 25 | ʼ78 | |||||
Acetic anhydride [108-24-7] | 5* | 21* | ʼ90 | |||||
Acetone [67-64-1] | 200 | 475 | ʼ72 | |||||
Acrylaldehyde [107-02-8] | 0.1 | 0.23 | ʼ73 | |||||
Acrylamide [79-06-1] | — | 0.1 | S | 2A | 2 | 2 | ʼ04 | |
Acrylonitrile [107-13-1] | 2 | 4.3 | S | 2Aψ | ʼ88 | |||
Allyl alcohol [107-18-6] | 1 | 2.4 | S | ʼ78 | ||||
2-Aminoethanol [141-43-5] | 3 | 7.5 | ʼ65 | |||||
Ammonia [7664-41-7] | 25 | 17 | ʼ79 | |||||
Aniline [62-53-3] | 1 | 3.8 | S | 1 | ʼ88 | |||
o-Anisidine [90-04-0] | 0.1 | 0.5 | S | 2B | ʼ96 | |||
p-Anisidine [104-94-9] | 0.1 | 0.5 | S | ʼ96 | ||||
Antimony and compounds (as Sb except stibine) [7440-36-0] | — | 0.1 | (ʼ13) | |||||
Arsenic and compounds (as As) [7440-38-2] | (Table III-2) | 1 | 1 | ʼ00 | ||||
Arsine [7784-42-1] | 0.01 | 0.032 | ʼ92 | |||||
0.1* | 0.32* | |||||||
Atrazine [1912-24-9] | 2 | 3 | ʼ15 | |||||
Benomyl [17804-35-2] | 1 | 2 | 2# | ʼ18 | ||||
Benzene [71-43-2] | (Table III-2) | S | 1 | ʼ97 | ||||
Benzyl alcohol [100-51-6] | — | 25* | 2 | ’19 | ||||
Beryllium and compounds (as Be) [7440-41-7] | — | 0.002 | 1ψ | 1 | 2 | ʼ63 | ||
Boron trifluoride [7637-07-2] | 0.3 | 0.83 | ʼ79 | |||||
Bromine [7726-95-6] | 0.1 | 0.65 | ʼ64 | |||||
Bromoform [75-25-2] | 1 | 10.3 | ʼ97 | |||||
1-Bromopropane [106-94-5] | 0.5 | 2.5 | 2B | 2 | ʼ12 | |||
2-Bromopropane [75-26-3] | (Table I-2) | S | 2B† | 1 | ʼ21 | |||
Buprofezin [69327-76-0] | — | 2 | ʼ90 | |||||
Butane (all isomers) [106-97-8] | 500 | 1,200 | ʼ88 | |||||
1-Butanol [71-36-3] | 50* | 150* | S | ʼ87 | ||||
2-Butanol [78-92-2] | 100 | 300 | ʼ87 | |||||
Butyl acetate [123-86-4] | 100 | 475 | ʼ94 | |||||
t-Butyl alcohol [75-65-0] | 50 | 150 | ʼ87 | |||||
Butylamine [109-73-9] | 5* | 15* | S | (ʼ94) | ||||
n-butyl-2,3-epoxy-propyl ether [2426-08-6] | 0.25 | 1.3 | 2B | 2 | 3 | ʼ16 | ||
Cadmium and compounds (as Cd) [7440-43-9] | — | 0.05 | 1ψ | 1 | ʼ76 | |||
Calcium cyanide (as CN) [592-01-8] | — | 5* | S | ʼ01 | ||||
Carbaryl [63-25-2] | — | 5 | S | ʼ89 | ||||
Carbon dioxide [124-38-9] | 5,000 | 9,000 | ʼ74 | |||||
Carbon disulfide [75-15-0] | 1 | 3.13 | S | 1# | ʼ15 | |||
Carbon monoxide [630-08-0] | 50 | 57 | 1 | ʼ71 | ||||
Carbon tetrachloride [56-23-5] | 5 | 31 | S | 2B | ʼ91 | |||
Chlorine [7782-50-5] | 0.5* | 1.5* | ʼ99 | |||||
Chlorobenzene [108-90-7] | 10 | 46 | ʼ93 | |||||
Chlorodifluoromethane [75-45-6] | 1,000 | 3,500 | 2 | ʼ87 | ||||
Chloroethane [75-00-3] | 100 | 260 | ʼ93 | |||||
Chloroform [67-66-3] | 3 | 14.7 | S | 2B | ʼ05 | |||
Chloromethane [74-87-3] | 50 | 100 | 2 | ʼ84 | ||||
Chloromethyl methyl ether (technical grade) [107-30-2] | — | — | 2A | ʼ92 | ||||
Chloropicrin [76-06-2] | 0.1 | 0.67 | ʼ68 | |||||
Chromium and compounds (as Cr) [7440-47-3] | 2 | 1 | 3 | ʼ89 | ||||
Chromium metal | — | 0.5 | ||||||
Chromium (III) compounds | — | 0.5 | ||||||
Chromium (VI) compounds | — | 0.05 | ||||||
Certain chromium (VI) compounds | — | 0.01 | 1 | |||||
Cobalt and compounds (without tungsten carbide) [7440-48-4] | — | 0.05 | 2B | 1 | 1 | ʼ92 | ||
Cresol (all isomers) | 5 | 22 | S | ʼ86 | ||||
Cumene [98-82-8] | 10 | 50 | S | 2B | ʼ19 | |||
Cyclohexane [110-82-7] | 150 | 520 | ʼ70 | |||||
Cyclohexanol [108-93-0] | 25 | 102 | ʼ70 | |||||
Cyclohexanone [108-94-1] | 25 | 100 | ʼ70 | |||||
Diazinon [333-41-5] | — | 0.1 | S | 2B | ʼ89 | |||
Diborane [19287-45-7] | 0.01 | 0.012 | ʼ96 | |||||
Dibutyl phthalate [84-74-2] | — | 5 | 2 | ʼ96 | ||||
o-Dichlorobenzene [95-50-1] | 25 | 150 | ʼ94 | |||||
p-Dichlorobenzene [106-46-7] | 10 | 60 | 2B | 3 | ʼ98 | |||
1,4-Dichloro-2-butene [764-41-0] | 0.002 | 2B | ʼ15 | |||||
3,3’-Dichloro-4,4’-diaminodiphenylmethane (MBOCA) [101-14-4] | — | 0.005 | S | 2Aψ | ʼ12 | |||
Dichlorodifluoromethane [75-71-8] | 500 | 2,500 | ʼ87 | |||||
1,1-Dichloroethane [75-34-3] | 100 | 400 | ʼ93 | |||||
1,2-Dichloroethane [107-06-2] | 10 | 40 | 2B | ʼ84 | ||||
2,2’-Dichloroethyl ether [111-44-4] | 15 | 88 | S | ʼ67 | ||||
1,2-Dichloroethylene [540-59-0] | 150 | 590 | ʼ70 | |||||
Dichloromethane [75-09-2] | 50 | 173 | S | 2A | ʼ99 | |||
100* | 347* | |||||||
2,4-Dichlorophenoxyacetic acid (2,4-D) [94-75-7] | — | 2 | S | 2 | ’19 | |||
1,2-Dichloropropane [78-87-5] | 1 | 4.6 | 1 | 2 | ʼ13 | |||
2,2-Dichloro-1,1,1-trifluoroethane [306-83-2] | 10 | 62 | ʼ00 | |||||
Diethylamine [109-89-7] | 10 | 30 | ʼ89 | |||||
Di(2-ethylhexyl) phthalate [117-81-7] | — | 5 | 2B | 1# | ʼ95 | |||
Diethyl phthalate [84-66-2] | — | 5 | ʼ95 | |||||
N,N-Dimethyl acetamide [127-19-5] | 10 | 36 | S | 2B | 2 | ʼ90 | ||
Dimethylamine [124-40-3] | 2 | 3.7 | 3 | ʼ16 | ||||
N,N-Dimethylaniline [121-69-7] | 5 | 25 | S | ʼ93 | ||||
N,N-Dimethylformamide (DMF) [68-12-2] | 10 | 30 | S | 2A | 2 | ʼ74 | ||
Dimethyl sulfate [77-78-1] | 0.1 | 0.52 | S | 2Aψ | ʼ80 | |||
Dimethyl terephthalate [120-61-6] | 8 | ʼ20 | ||||||
1,2-Dinitrobenzene [528-29-0] | 0.15 | 1 | S | ʼ94 | ||||
1,3-Dinitrobenzene [99-65-0] | 0.15 | 1 | S | ʼ94 | ||||
1,4-Dinitrobenzene [100-25-4] | 0.15 | 1 | S | ʼ94 | ||||
1,4-Dioxane [123-91-1] | 1 | 3.6 | S | 2B | ʼ15 | |||
Diphenylmethane-4,4’-diiso-cyanate (MDI) [101-68-8] | — | 0.05 | 1 | ʼ93 | ||||
Dusts | (Table I-3) | |||||||
2,3-Epoxypropyl methacrylate (Glycidyl methacrylate, GMA) [106-91-2] | 0.01 | 0.06 | S | 2A | 2 | 3 | ʼ18 | |
Ethyl acetate [141-78-6] | 200 | 720 | ʼ95 | |||||
Ethylamine [75-04-7] | 10 | 18 | ʼ79 | |||||
Ethylbenzene [100-41-4] | 20 | 87 | S | 2B | 2 | ʼ20 | ||
Ethylenediamine [107-15-3] | 10 | 25 | S | 2 | 2 | ʼ91 | ||
Ethylene glycol monobutyl ether [111-76-2] | 20* | 97* | S | 2 | ʼ17 | |||
Ethylene glycol monoethyl ether [110-80-5] | 5 | 18 | S | 2 | ʼ85 | |||
Ethylene glycol monoethyl ether acetate [111-15-9] | 5 | 27 | S | 2 | ʼ85 | |||
Ethylene glycol monomethyl ether [109-86-4] | 0.1 | 0.31 | S | 1 | ʼ09 | |||
Ethylene glycol monomethyl ether acetate [110-49-6] | 0.1 | 0.48 | S | 1 | ʼ09 | |||
Ethylene oxide [75-21-8] | 1 | 1.8 | 1ψ | 2 | 1 | ʼ90 | ||
Ethylenimine [151-56-4] | 0.05 | 0.09 | S | 2B | 3 | ʼ18 | ||
Ethyl ether [60-29-7] | 400 | 1,200 | (ʼ97) | |||||
2-Ethy1-1-hexanol [104-76-7] | 1 | 5.3 | 3† | ʼ16 | ||||
Ethylidene norbornene [16219-75-3] | 2 | 10 | 3 | ʼ18 | ||||
Etofenprox [80844-07-1] | — | 3 | ʼ95 | |||||
Fenitrothion [122-14-5] | — | 1 | S | ʼ81 | ||||
Fenobucarb [3766-81-2] | — | 5 | S | ʼ89 | ||||
Fenthion [55-38-9] | — | 0.2 | S | ʼ89 | ||||
Flutolanil [66332-96-5] | — | 10 | ʼ90 | |||||
Formaldehyde [50-00-0] | 0.1 | 0.12 | 2A | 2 | 1 | ʼ07 | ||
0.2* | 0.24* | |||||||
Formic acid [64-18-6] | 5 | 9.4 | ʼ78 | |||||
Fthalide [27355-22-2] | — | 10 | ʼ90 | |||||
Furfural [98-01-1] | 2.5 | 9.8 | S | (ʼ89) | ||||
Furfuryl alcohol [98-00-0] | 5 | 20 | 2B | ʼ78 | ||||
Gasoline [8006-61-9] | 100b | 300b | 2B | ʼ85 | ||||
Glyphosate [1071-83-6] | (Table I-2) | 2B† | 3† | ’21 | ||||
Glutaraldehyde [111-30-8] | 0.03* | 1 | 1 | ʼ06 | ||||
Heptane [142-82-5] | 200 | 820 | ʼ88 | |||||
Hexachlorobutadiene [87-68-3] | 0.01 | 0.12 | S | ʼ13 | ||||
Hexane [110-54-3] | 40 | 140 | S | ʼ85 | ||||
Hexane-1,6-diisocyanate (HDI) [822-06-0] | 0.005 | 0.034 | 1 | ʼ95 | ||||
Hydrazine (anhydrous) and Hydrazine hydrate [302-01-2/7803-57-8] | 0.1 | 0.13 and 0.21 | S | 2A | 1 | ʼ98 | ||
Hydrogen chloride [7647-01-0] | 2* | 3.0* | ʼ14 | |||||
Hydrogen cyanide [74-90-8] | 5 | 5.5 | S | ʼ90 | ||||
Hydrogen fluoride [7664-39-3] | 3* | 2.5* | S | (ʼ20) | ||||
Hydrogen selenide [7783-07-5] | 0.05 | 0.17 | ʼ63 | |||||
Hydrogen sulfide [7783-06-4] | 5 | 7 | ʼ01 | |||||
Indium and compounds [7440-74-6] | (Table II-1) | 2A | ʼ07 | |||||
Iodine [7553-56-2] | 0.1 | 1 | 2 | ʼ68 | ||||
Isobutyl alcohol [78-83-1] | 50 | 150 | ʼ87 | |||||
Isopentyl alcohol [123-51-3] | 100 | 360 | ʼ66 | |||||
Isoprene [78-79-5] | 3 | 8.4 | 2B | ʼ17 | ||||
Isopropyl acetate [108-21-4] | 100 | ʼ17 | ||||||
Isopropyl alcohol [67-63-0] | 400* | 980* | ʼ87 | |||||
Isoprothiolane [50512-35-1] | — | 5 | ʼ93 | |||||
Lead and compounds (as Pb except alkyl lead compounds) [7439-92-1] | — | 0.03 | 2B | 1# | ʼ16 | |||
Lithium hydroxide [1310-65-2] | — | 1 | ʼ95 | |||||
Malathion [121-75-5] | — | 10 | S | 2B | ʼ89 | |||
Maleic anhydride [108-31-6] | 0.1 | 0.4 | 2 | 2 | (ʼ15) | |||
0.2* | 0.8* | |||||||
Manganese and its compounds (as Mn except organic compounds) [7439-96-5] | (Table I-2) | 2 | ʼ21 | |||||
Man-made mineral fibers** | ʼ03 | |||||||
Ceramic fibers, Micro glass fibers | — | — | 2B | |||||
Continuous filament glass fibers, | 1 (fiber/ml) | |||||||
Glass wool fibers, Rock wool fibers, Slag wool fibers | ||||||||
Mepronil [55814-41-0] | — | 5 | ʼ90 | |||||
Mercury vapor [7439-97-6] | — | 0.025 | 2 | ʼ98 | ||||
Methacrylic acid [79-41-4] | 2 | 7.0 | ʼ12 | |||||
Methanol [67-56-1] | 200 | 260 | S | 2 | ʼ63 | |||
Methyl acetate [79-20-9] | 200 | 610 | ʼ63 | |||||
Methyl acrylate [96-33-3] | 2 | 7 | 2B | 2 | ʼ04 | |||
Methylamine [74-89-5] | 5 | 6.5 | ʼ19 | |||||
Methyl bromide [74-83-9] | 1 | 3.89 | S | ʼ03 | ||||
Methyl n-butyl ketone [591-78-6] | 5 | 20 | S | ʼ84 | ||||
Methylcyclohexane [108-87-2] | 400 | 1,600 | ʼ86 | |||||
Methylcyclohexanol [25639-42-3] | 50 | 230 | ʼ80 | |||||
Methylcyclohexanone [1331-22-2] | 50 | 230 | S | ʼ87 | ||||
Methyl methacrylate [80-62-6] | 8.3 | 2 | 2 | ʼ12 | ||||
4,4’-Methylenedianiline [101-77-9] | — | 0.4 | S | 2B | ʼ95 | |||
Methyl ethyl ketone [78-93-3] | 200 | 590 | ʼ64 | |||||
Methyl isobutyl ketone [108-10-1] | 50 | 205 | 2B | ʼ84 | ||||
N-Methyl-2-pyrrolidone [872-50-4] | 1 | 4 | S | ʼ02 | ||||
Methyltetrahydrophthalic anhydride [11070-44-3] | 0.007 | 0.05 | 1 | ʼ02 | ||||
0.015* | 0.1* | |||||||
Nickel [7440-02-0] | — | 1 | 2 | 1 | 3 | ʼ11 | ||
Nickel carbonyl [13463-39-3] | 0.001 | 0.007 | ʼ66 | |||||
Nickel compounds (total dusts) (as Ni) [7440-02-0], | 2B | 3 | ʼ11 | |||||
Nickel compounds, soluble | 0.01 | ʼ11 | ||||||
Nickel compounds, not soluble | 0.1 | ʼ11 | ||||||
Nickel smelting dusts [7440-02-0] | (Table III-2) | 1 | ʼ11 | |||||
Nitric acid [7697-37-2] | 2 | 5.2 | ʼ82 | |||||
p-Nitroaniline [100-01-6] | — | 3 | S | ʼ95 | ||||
Nitrobenzene [98-95-3] | 1 | 5 | S | 2B | (ʼ88) | |||
p-Nitrochlorobenzene [100-00-5] | 0.1 | 0.64 | S | ʼ89 | ||||
Nitrogen dioxide [10102-44-0] | (pending) | ʼ61 | ||||||
Nitroglycerin [55-63-0] | 0.05* | 0.46* | S | ʼ86 | ||||
Nitroglycol [628-96-6] | 0.05 | 0.31 | S | ʼ86 | ||||
Nonane [111-84-2] | 200 | 1,050 | ʼ89 | |||||
Octane [111-65-9] | 300 | 1,400 | ʼ89 | |||||
Oil mist, mineral | — | 3 | 1ψ | ʼ77 | ||||
Ozone [10028-15-6] | 0.1 | 0.2 | ʼ63 | |||||
Parathion [56-38-2] | — | 0.1 | S | (ʼ80) | ||||
Pentachlorophenol [87-86-5] | — | 0.5 | S | 2 | (ʼ89) | |||
Pentane [109-66-0] | 300 | 880 | ʼ87 | |||||
Pentyl acetate, all isomers [628-63-7; 123-92-2; 626-38-0; 620-11-1; 625-16-1; 624-41-9; 926-41-0] | 50 | 266.3 | ʼ08 | |||||
100* | 532.5* | |||||||
Perfluorooctanoic acid [335-67-1] | 0.005c | 2B | 1# | ʼ08 | ||||
Phenol [108-95-2] | 5 | 19 | S | 3 | ʼ78 | |||
m-Phenylenediamine [108-45-2] | — | 0.1 | 3 | ʼ99 | ||||
o-Phenylenediamine [95-54-5] | — | 0.1 | 2B | 3 | ʼ99 | |||
p-Phenylenediamine [106-50-3] | — | 0.1 | 1 | ʼ97 | ||||
Phosgene [75-44-5] | 0.1 | 0.4 | ʼ69 | |||||
Phosphine [7803-51-2] | 0.3* | 0.42* | ʼ98 | |||||
Phosphoric acid [7664-38-2] | — | 1 | (ʼ90) | |||||
Phosphorus (yellow) [7723-14-0] | — | 0.1 | (ʼ88) | |||||
Phosphorus pentachloride [10026-13-8] | 0.1 | 0.85 | ʼ89 | |||||
Phosphorus trichloride [7719-12-2] | 0.2 | 1.1 | ʼ89 | |||||
Phthalic anhydride [85-44-9] | 0.33* | 2* | 1 | ʼ98 | ||||
o-Phthalodinitrile [91-15-6] | 0.01 | S | ʼ09 | |||||
Picric acid | — | — | 2 | ʼ14 | ||||
Platinum, soluble salts (as Pt) [7440-06-4] | — | 0.001 | 1 | 1 | ʼ00 | |||
Polychlorobiphenyls | — | 0.01 | S | 1ψ | 1 | ʼ06 | ||
Potassium cyanide (as CN) [151-50-8] | — | 5* | S | ʼ01 | ||||
Potassium hydroxide [1310-58-3] | — | 2* | ʼ78 | |||||
Propyl acetate [109-60-4] | 200 | 830 | ʼ70 | |||||
Propyleneimine (2-Methylaziridine) | 0.2 | 0.45 | S | 2B | ʼ17 | |||
Pyridaphenthion [119-12-0] | — | 0.2 | S | ʼ89 | ||||
Rhodium (soluble compounds, as Rh) [7440-16-6] | — | 0.001 | 2 | ʼ07 | ||||
Selenium and compounds (as Se, except SeH2 and SeF6) [7782-49-2] | — | 0.1 | ʼ00 | |||||
Silane [7803-62-5] | 100* | 130* | ʼ93 | |||||
Silicon carbide whisker [409-21-2; 308076-74-6] | — | 0.1 (fiber/ml) | 2A | ’19 | ||||
Silver and compounds (as Ag) [7440-22-4] | — | 0.01 | ʼ91 | |||||
Sodium cyanide (as CN) [143-33-9] | — | 5* | S | ʼ01 | ||||
Sodium hydroxide [1310-73-2] | — | 2* | ʼ78 | |||||
Styrene [100-42-5] | 20 | 85 | S | 2B | 2 | ʼ99 | ||
Sulfur dioxide [7446-09-5] | (pending) | ʼ61 | ||||||
Sulfuric acid [7664-93-9] | — | 1* | ʼ00 | |||||
Sulfur monochloride [10025-67-9] | 1* | 5.5* | ʼ76 | |||||
1,1,2,2-Tetrachloroethane [79-34-5] | 1 | 6.9 | S | 2B | ʼ84 | |||
Tetrachloroethylene [127-18-4] | (pending) | S | 2B | 3 | ʼ72 | |||
Tetraethoxysilane [78-10-4] | 10 | 85 | ʼ91 | |||||
Tetraethyl lead (as Pb) [78-00-2] | — | 0.075 | S | ʼ65 | ||||
Tetrahydrofuran [109-99-9] | 50 | 148 | S | 2B | ʼ15 | |||
Tetramethoxysilane [681-84-5] | 1 | 6 | ʼ91 | |||||
Thiuram [137-26-8] | 0.1 | 1 | ʼ08 | |||||
Titanium dioxide (nanoparticle, as Ti) [13463-67-7] | — | 0.3 | 2B | ʼ13 | ||||
Toluene [108-88-3] | 50 | 188 | S | 1 | (ʼ13) | |||
Toluene diisocyanates [26471-62-5] | 0.005 | 0.035 | 2B | 1 | 2 | ʼ92 | ||
0.02* | 0.14* | |||||||
Trichlorhon [52-68-6] | 0.2 | S | ʼ10 | |||||
o-Toluidine [95-53-4] | 1 | 4.4 | S | 1ψ | ʼ91 | |||
1,1,1-Trichloroethane [71-55-6] | 200 | 1,090 | ʼ74 | |||||
1,1,2-Trichloroethane [79-00-5] | 10 | 55 | S | (ʼ78) | ||||
Trichloroethylene [79-01-6] | 25 | 135 | 1ψ | 1 | 3 | ʼ15 | ||
Trichlorofluoromethane [75-69-4] | 1,000* | 5,600* | ʼ87 | |||||
1,1,2-Trichloro-1,2,2-trifluoroethane [76-13-1] | 500 | 3,800 | ʼ87 | |||||
Tricyclazole [41814-78-2] | — | 3 | ʼ90 | |||||
Trimellitic anhydride [552-30-7] | 0.0005 | S | 1 | ʼ15 | ||||
0.004* | ||||||||
1,2,3-Trimethylbenzene [526-73-8] | 25 | 120 | ʼ84 | |||||
1,2,4-Trimethylbenzene [95-63-6] | 25 | 120 | ʼ84 | |||||
1,3,5-Trimethylbenzene [108-67-8] | 25 | 120 | ʼ84 | |||||
Trinitrotoluene (all isomers) | — | 0.1 | S | ʼ93 | ||||
Turpentine | 50 | 280 | 1 | ʼ91 | ||||
Vanadium compounds | 2 | |||||||
Ferrovanadium dust [12604-58-9] | — | 1 | ʼ68 | |||||
Vanadium pentoxide [1314-62-1] | — | 0.05 | 2B | ʼ03 | ||||
Vinyl chloride [75-01-4] | (Table III-2) | 1ψ | ʼ17 | |||||
Xylene (all isomers and their mixture) | 50 | 217 | ʼ01 | |||||
Xylene for industrial use | 2 | |||||||
Xylene (ortho-, meta-, para-xylene and their mixture) | 3 | |||||||
Zinc oxide nanoparticle [1314-13-2] | (Table I-2) | ʼ21 |
1. ppm: parts of vapors and gases per million of substance in air by volume at 25°C and atmospheric pressure (760 torr, 1,013 hPa); OELs in ppm are converted to those in mg/m3, in which the values are rounded off to 2 significant digits.
2. ( ) in the year of proposal column indicates that revision was done in the year without change of the OEL value.
3. *: Occupational Exposure Limit-Ceiling; exposure concentration must be kept below this level.
**: Fibers longer than 5 μm and with an aspect ratio equal to or greater than 3:1 as determined by the membrane filter method at 400×magnification phase contrast illumination.
ψ: Substance whose OEL is set based on non-carcinogenic health effects; see III.
a: Exposure concentration should be kept below a detectable limit though OEL is set at 2.5 ppm provisionally.
b: OEL for gasoline is 300 mg/m3, and an average molecular weight is assumed to be 72.5 for conversion to ppm units.
c: Not applicable to women of child bearing potential.
#: Precaution should be taken for exposure lower than the OEL-M or OEL-B. As for reproductive toxicity, it is generally known that there is a sensitive period, during pregnancy for example, and such effects of this substance have been identified.
†: Provisional.
Substance [CAS No.] | OEL | Skin absorption | Class of carcinogenicity | Class of sensitizing potential | Reproductive Toxicants | Year of proposal | ||
---|---|---|---|---|---|---|---|---|
ppm | mg/m3 | Airway | Skin | |||||
Acetaldehyde [75-07-0] | 10* | 18* | 2B‡ | ’21 | ||||
2-Bromopropane [75-26-3] | 0.5 | 2.5 | S‡ | 2B | 1‡ | ’21 | ||
Glyphosate [1071-83-6] | 1.5 | 2B | 3 | ’21 | ||||
Manganese and its compounds (as Mn except organic compounds) [7439-96-5] | 0.02 (respirable particulate matter) 0.1 (Total particulate matter) | 2‡ | ’21 | |||||
Zinc oxide nanoparticle [1314-13-2] | 0.5 | ’21 |
Note: see Table I-1
‡: Not provisional
I. Respirable crystalline silicaψ, * OEL-C 0.03 mg/m3 II. Dusts other than I | |||
Dusts | OEL (mg/m3) | ||
Respirable dust* | Total dust** | ||
Class 1 | Activated charcoal, Alumina, Aluminum, Bentonite, Diatomite, Graphite, Kaolinite, Pagodite, Pyrites, Pyrite cinder, Talc | 0.5 | 2 |
Class 2 | Dusts containing less than 3% cry stalline silica, Bakelite, Carbon black, Coal, Cork dust, Cotton dust, Iron oxide, Grain dust, Joss stick material dust, Marble, Portland cement, Titanium oxide, Zinc oxide | 1 | 4 |
Class 3 | Limestone‡, Inorganic and organic dusts other than Classes 1 and 2b | 2 | 8 |
Asbestos*** | (Table III-2) |
1. a, OELs for dusts are set to prevent from Class 2 pneumoconiosis, while no other toxicities are considered
b, OEL for ‘inorganic and organic dusts other than Classes 1 and 2’ is a reference value assigned for dusts that are insoluble or poorly soluble in water to prevent from pneumoconiosis caused by inhaling large amount of those; thus, be aware that unknown toxocity may be developed even below this value
2.*: Respirable crystalline silica and respirable dust consist of particles captured by the following collection efficiency, R (dae).
R (dae)=0.5[1+exp (–0.06dae)] [1–F (x)]
dae: aerodynamic diameter of particle (μm), F (x): cumulative distribution function of the standardized normal variable
x=ln(dae/Γ)/ln(Σ), ln natural logarithm, Γ=4.25 μm, Σ=1.5
**: Total dust comprises particles with a flow speed of 50 to 80 cm/sec at the entry of a particle sampler.
***: Fibers longer than 5 μm and with an aspect ratio equal to or greater than 3:1 as determined by the membrane filter method at 400×magnification (4 mm objective) phase contrast illumination.
3. ‡: Do not include asbestos nor ≥1% crystalline silica.
4. ψ: Substance whose OEL is set based on non-carcinogenic health effects; see III.
5. OEL for wood dust is under consideration.
Other working conditions, such as work intensity, heat stress and abnormal atmospheric pressure, must be considered, since their co-existence could cause an increase in the inhaled dose of a chemical substance, thereby intensifying its effects on workers’ health.
5. OEL for exposure to mixture of chemical substancesOEL-M values listed in Table I-1 and I-2 are applicable in cases where the substance exists alone. When workers are exposed to a mixture of chemical substances and there is no reliable evidence to the contrary that the effects of the chemicals are assumed to be additive, the effects should be assumed as additive.
The users should refer not to each OEL-M value, but rather to the following equation:
I=C1/T1+C2/T2+...+Ci/Ti+...+Cn/Tn
Ci=mean exposure concentration for each component i
Ti=OEL-M for each component i
Any value of I exceeding 1 indicates an exposure that is above OEL.
Biological monitoring in the occupational setting consists of (1) measuring the concentration of a chemical substance or its metabolite (s) in biological specimens, and/or (2) determining early health effects by using biological specimens which are predictors or warning signs of the occurrence of adverse health effects.
Occupational Exposure Limit Based on Biological Monitoring (OEL-B) is defined as the reference values to the data obtained by biological monitoring at or below (depending on agents, above) which the adverse health effects do not appear in most workers who are exposed to the chemical substances.
2. Characteristics of OEL-B(1) In setting OEL-B, consideration is given to the exposure-effect and/or exposure-response relationships between biological monitoring values and health effects, or to the relationship between biological monitoring values and OEL-Ms.
(2) There is a possibility that exposure concentration of chemical substances in the workplace will not closely associate with biological monitoring values due to various factors, e.g., intra- and inter-individual variation in metabolism, social habits such as smoking and alcohol consumption, working conditions, working time, skin absorption, use of personal protective equipment, and possible exposure to the substances outside the workplace. Biological monitoring values could exceed OEL-B even though exposure to the chemical substances is below OEL-M, and vice versa. Both OEL-M and OEL-B must be satisfied at the workplace.
(3) Biological specimens should be collected at the time that is most likely to represent the particular exposure to the substances concerned, or at the time most likely to predict occurrence of the particular adverse health effects. Only biological monitoring values measured under this condition can be referred to OEL-B.
(4) OEL-B is applied to cases of single-substance absorption. For exposure to a mixture of substances, interactions in terms of absorption, metabolism, accumulation, excretion and health effects must also be considered.
Substance | Assay material | Parameter | OEL-B | Sampling time | Year of proposal |
---|---|---|---|---|---|
Acetone | urine | Acetone | 40 mg/l | Within 2 h prior to end of shift | ʼ01 |
2-Butoxyethanol and 2-Butoxyethyl acetate | urine | Butoxyacetic acid | 200 mg/g·Cr | End of shift | ʼ08 |
Cadmium and its compounds | blood | Cadmium | 5 µg/l† | Not critical | ’21 |
urine | Cadmium | 5 µg/g·Cr† | Not critical | ’21 | |
Carbon disulfide | urine | 2-Thiothiazolidine-4-carboxylic acid | 0.5 mg/g·Cr | End of shift (Avoid sizable intake of brassica vegetables) | ʼ15 |
Cobalt and inorganic compounds (except cobalt oxides) | blood | Cobalt | 3 μg/l | Within 2 h prior to end of shift at end of work week | ʼ05 |
urine | Cobalt | 35 μg/l | Within 2 h prior to end of shift at end of work week | ʼ05 | |
Chlorobenzene | urine | 4-Chlorocatechol (hydrolysis) | 120 mg/g·Cr | End of shift | ʼ08 |
3,3’-Dichloro-4,4’-diaminodiphenyl-methane (MBOCA) | urine | total MBOCA | 50 μg/g·Cr | End of shift at end of workweek | ʼ94 |
Dichloromethane | urine | Dichloromethane | 0.2 mg/l | End of shift | ʼ05 |
Ethylbenzene | urine | Mandelic acid | 150 mg/g·Cr† | End of shift | ’21 |
urine | Mandelic acid+ Phenylglyoxylic acid | 200 mg/g·Cr† | End of shift at end of workweek | ’21 | |
urine | Ethylbenzene | 15 µg/l† | End of shift | ’21 | |
Hexane | urine | 2,5-Hexanedione | 3 mg/g·Cr (after acid hydrolysis) | End of shift at end of workweek | ʼ94 |
urine | 2,5-Hexanedione | 0.3 mg/g·Cr (without acid hydrolysis) | End of shift at end of workweek | ʼ94 | |
Indium and compounds | serum | Indium | 3 μg/l | Not critical | ʼ07 |
Lead and compounds (except alkyl lead compounds) | blood | Lead | 15 μg/100 ml | Not critical | ʼ13 |
blood | Protoporphyrin | 200 μg/100 ml·RBC | Not critical | ʼ94 | |
80 μg/100 ml·blood | (After one month or more since consecutive exposure) | ʼ94 | |||
urine | δ-Aminolevulinic acid | 5 mg/l | Not critical | ʼ94 | |
(After one month or more since consecutive exposure) | |||||
Mercury and compounds (except alkyl mercury compounds) | urine | total inorganic mercury | 35 μg/g·Cr | Not critical | ʼ93 |
Methanol | urine | Methanol | 20 mg/l | End of shift | ʼ10 |
Methylethylketone | urine | Methylethylketone | 5 mg/l | End of shift or A few hours after high exposure | ʼ06 |
Methyl isobutyl ketone | urine | Methyl isobutyl ketone | 1.7 mg/l | End of shift | ʼ07 |
Phenol | urine | Phenol | 250 mg/g·Cr | End of shift | ʼ08 |
Polychlorobiphenyls (PCBs) | blood | total PCB | 25 μg/l | Not critical | ʼ06 |
Styrene | urine | Mandelic acid + Phenylglyoxylic acid | 430 mg/l | End of shift at end of work week | ʼ07 |
blood | Styrene | 0.2 mg/l | End of shift at end of work week | ʼ07 | |
Tetrahydrofuran | urine | Tetrahydrofuran | 2 mg/l | End of shift | (ʼ15) |
Toluene | blood | Toluene | 0.6 mg/l | Within 2 h prior to end of shift at end of work week | ʼ99 |
urine | Toluene | 0.06 mg/l | ʼ99 | ||
Trichloroethylene | urine | total trichloro-compounds | 150 mg/l | Within 2 h prior to end of shift at end of work week | ʼ99 |
urine | Trichloroethanol | 100 mg/l | ʼ99 | ||
urine | Trichloroacetic acid | 50 mg/l | |||
Xylene | urine | total (o-, m-, p-) methylhippuric acid | 800 mg/l | End of shift at end of work week | ʼ06 |
†: Provisional
See the JSOH website for brief summary of OEL documentation at http://sanei.or.jp/oel-eng
JSOH classifies the occupational carcinogens based primarily on the epidemiological evidences1), but the results of the animal experiments and their extrapolation to human are also considered. The classification is made by strength of the evidence, but does not reflect the carcinogenic potency.
JSOH considers that the classification of occupational carcinogens proposed by the International Agency for Research on Cancer (IARC)2) is appropriate in principle. JSOH also discussed the classification of several agents based on other information sources and finalized the list of occupational carcinogens in Table III-1a, b, and c. Group 1 includes agents that are carcinogenic to humans. Group 2 indicates the agents which are probably or possibly carcinogenic to humans, classifying them into two sub-groups on the basis of degree of evidence: Group 2A is assigned to the agents with more sufficient evidence (probably carcinogenic to humans), Group 2B to those with less (possibly carcinogenic to humans).
Substance | CAS No. | Year of proposal |
---|---|---|
4-Aminobiphenyl | 92-67-1 | ʼ81, ʼ86 |
Arsenic and inorganic arsenic compounds* | 7440-38-2 | ʼ81, ʼ86, (ʼ00) |
Asbestos | 1332-21-4 | ʼ81, ʼ86, (ʼ00) |
Benzene | 71-43-2 | ʼ81, ʼ86, (ʼ97), (ʼ19) |
Benzidine | 92-87-5 | ʼ81, ʼ86 |
Benzo [a] pyrene | 50-32-8 | ʼ86, ʼ17 |
Benzotrichloride | 98-07-7 | ʼ81, ʼ86, (ʼ01) |
Beryllium and compounds* | 7440-41-7 | ʼ86, ʼ16 |
Bis (chloromethyl) ether | 542-88-1 | ʼ81, ʼ86 |
1,3-Butadiene | 106-99-0 | ʼ91, ʼ95, ʼ01 |
Cadmium and compounds* | 7440-43-9 | ʼ86, ʼ91, ʼ96 |
Chromium (VI) compounds | 18540-29-9 | ʼ81, ʼ86 |
Coal-tar pitch volatiles | — | ʼ81, ʼ86, (ʼ04) |
Coal-tars | 8007-45-2 | ʼ81, ʼ86, (ʼ04) |
1,2-Dichloropropane | 78-87-5 | ʼ13, ʼ14 |
Erionite | 12510-42-8 | ʼ91 |
Ethylene oxide | 75-21-8 | ʼ86, ʼ90, ʼ96 |
Ionizing radiation | — | ʼ12 |
Mineral oils (untreated and mildly treated) | — | ʼ81, ʼ86, ʼ91 |
2-Naphthylamine | 91-59-8 | ʼ81, ʼ86 |
Nickel smelting dusts* | 7440-02-0 | ʼ81, ʼ86, ʼ91, (ʼ09) |
Polychlorinated biphenyls (PCB) | 1336-36-3, 53469-21-9, 11097-69-1 | ʼ86, ʼ91, ʼ16 |
Shale oils | 68308-34-9 | ʼ95 |
Silica (crystalline) | 14808-60-7 | ʼ91, ʼ01 |
Soots | — | ʼ81, ʼ86 |
Sulphur dichlorodiethyl | 505-60-2 | ʼ86 |
Talc containing asbestiform fibers | 14807-96-6 | ʼ91 |
2,3,7,8-Tetrachlorodibenzo-p-dioxin | 1746-01-6 | ʼ86, ʼ00 |
Tobacco smoke | — | ʼ10 |
o-Toluidine | 95-53-4 | ʼ86, ʼ95, ʼ01, ʼ16 |
Trichloroethylene | 79-01-6 | ʼ96, ʼ15 |
UV radiation from welding† | — | ’21 |
Vinyl chloride | 75-01-4 | ʼ81, ʼ86 |
Welding fume† | — | ’21 |
Wood dust | — | ʼ98 |
*Evaluation does not necessarily apply to all individual chemicals within the group.
( ) in the year of proposal indicates year of reconsideration resulting in no classification change.
† Provisional
Substance | CAS No. | Year of proposal |
---|---|---|
Acrylamide | 79-06-1 | ʼ91, ʼ95, (ʼ04) |
Acrylonitrile | 107-13-1 | ʼ86 |
Benzal chloride | 98-87-3 | ʼ91, ʼ01 |
Benzyl chloride | 100-44-7 | ʼ91, ʼ01 |
Chloromethyl methyl ether (technical grade) | 107-30-2 | ʼ92, (ʼ01) |
4-Chloro-o-toluidine | 95-69-2 | ʼ91, ʼ01 |
CI Direct Black 38** | 1937-37-7 | ʼ86, ʼ91, ʼ95, ʼ01, (ʼ15) |
CI Direct Blue 6** | 2602-46-2 | ʼ86, ʼ91, ʼ95, ʼ01, (ʼ15) |
CI Direct Brown 95** | 16071-86-6 | ʼ86, ʼ91, ʼ95, ʼ01, (ʼ15) |
Cobalt metal with tungsten carbide | 7440-48-4, 12070-12-1 | ʼ16 |
Creosotes | 8001-58-9 | ʼ91 |
1,2-Dibromoethane | 106-93-4 | ʼ86, ʼ95, ʼ01 |
3,3’-Dichloro-4,4’-diaminodiphenylmethane (MBOCA) | 101-14-4 | ʼ93, (ʼ12) |
Dichloromethane | 75-09-2 | ʼ91, ʼ14, ʼ15 |
Diethyl sulphate | 64-67-5 | ʼ86 |
N,N-Dimethylformamide | 68-12-2 | ’91, ’20 |
Dimethyl sulphate | 77-78-1 | ʼ86 |
Dimethylcarbamoyl chloride | 79-44-7 | ʼ86, ʼ91 |
Epichlorohydrin | 106-89-8 | ʼ86, ʼ91 |
2,3-Epoxypropyl methacrylate (Glycidyl methacrylate, GMA) | 106-91-2 | ʼ18 |
Formaldehyde | 50-00-0 | ʼ86, ʼ91, (ʼ07), (ʼ17) |
Glycidol | 556-52-5 | ʼ01 |
Hydrazine (Hydrazine anhydrous and Hydrazine hydrate) | 302-01-2, 7803-57-8 | ’86, (ʼ98), ʼ19 |
Indium and compounds (inorganic, hardly, soluble) | 7440-74-6 | ʼ13, (ʼ17) |
2-Nitrotoluene | 88-72-2 | ʼ18 |
PAHs (Cyclopenta [c,d] pyrene, Dibenz [a,h] anthracene, Dibenz [a,j] acridine, Dibenzo [a,l] pyrene, 1-Nitropyrene, 6-Nitrochrysene) | 27208-37-3, 53-70-3, 224-42-0, 191-30-0, 5522-43-0, 7496-02-8 | ʼ16 |
1,3-Propane sultone | 1120-71-4 | ʼ91, ʼ17 |
Silicon carbide whisker | 409-21-2, 308076-74-6 | ʼ19 |
Styrene oxide | 96-09-3 | ʼ92, (ʼ18) |
1,2,3-Trichloropropane | 96-18-4 | ʼ01 |
Tris (2,3-dibromopropyl) phosphate | 126-72-7 | ʼ91 |
Vinyl bromide | 593-60-2 | ʼ91 |
Vinyl fluoride | 75-02-5 | ʼ98 |
**Dyes metabolized to benzidine.
†Provisional
( ) in the year of proposal indicates year of reconsideration resulting in no classification change.
Substance | CAS No. | Year of proposal |
---|---|---|
Acetamide | 60-35-5 | ʼ91 |
Acetoaldehyde | 75-07-0 | ʼ91 |
Acrylic acid methyl | 96-33-3 | ʼ19 |
o-Aminoazotoluene | 97-56-3 | ʼ91 |
p-Aminoazobenzene | 60-09-3 | ʼ91 |
2-Amino-4-chlorophenol | 95-85-2 | ʼ19 |
Amitrole | 61-82-5 | ʼ86 |
Antimony trioxide | 1309-64-4 | ʼ91, (ʼ13) |
o-Anisidine | 90-04-0 | ʼ91, (ʼ96) |
Anthraquinone | 84-65-1 | ʼ15 |
Auramine (technical grade) | 492-80-8 | ʼ86 |
Benzofuran | 271-89-6 | ʼ15 |
Benzophenone | 119-61-9 | ʼ15 |
Benzoyl chloride | 98-88-4 | ʼ16 |
Benzyl violet 4B | 1694-09-3 | ʼ91 |
2,2-Bis (bromomethyl) propane-1,3-diol | 3296-90-0 | ʼ01 |
Bitumens | 8052-42-4 | ʼ91 |
1-Bromo-3-chloropropane | 109-70-6 | ’20 |
Bromodichloromethane | 75-27-4 | ʼ95 |
1-Bromopropane | 106-94-5 | ʼ17 |
2-Bromopropane† | 75-26-3 | ’21 |
1-tert-Butoxy-2-propanol | 57018-52-7 | ʼ18 |
n-Butyl-2,3-epoxypropyl ether | 2426-08-6 | ʼ16 |
β-Butyrolactone | 3068-88-0 | ʼ95 |
Carbon black | 1333-86-4 | ʼ91 |
Carbon tetrachloride | 56-23-5 | ʼ86 |
Catechol | 120-80-9 | ʼ01 |
Chlordane | 57-74-9 | ʼ01 |
Chlordecone (Kepone) | 143-50-0 | ʼ01 |
Chlorendic acid | 115-28-6 | ʼ91 |
Chlorinated paraffins | — | ʼ91 |
p-Chloroaniline | 106-47-8 | ʼ95 |
4-Chlorobenzotrifluoride | 98-56-6 | ’20 |
Chloroform | 67-66-3 | ʼ86, (ʼ05) |
1-Chloro-2-methylpropene | 513-37-1 | ʼ01 |
3-Chloro-2-methylpropene | 563-47-3 | ʼ01, (ʼ17) |
Chlorophenoxy acetic acid herbicides* | — | ʼ86 |
p-Chloro-o-phenylenediamine | 95-83-0 | ʼ91 |
Chloroprene | 126-99-8 | ʼ01 |
Chlorothalonil | 1897-45-6 | ʼ01 |
CI acid red 114 | 6459-94-5 | ʼ95 |
CI basic red 9 | 569-61-9 | ʼ95 |
CI direct blue 15 | 2429-74-5 | ʼ95 |
CI direct blue 218† | 28407-37-6 | ’21 |
Citrus red No.2 | 6358-53-8 | ʼ91 |
Cobalt and compounds (without tungsten carbide)* | 7440-48-4 | ʼ95, (ʼ16) |
p-Cresidine | 120-71-8 | ʼ91 |
Crotonaldehyde† | 4170-30-3 | ’21 |
Cumene | 98-82-8 | ʼ15, (ʼ19) |
Dantron | 117-10-2 | ʼ15 |
N,N’-Diacetyl benzidine | 613-35-4 | ʼ91 |
2,4-Diaminoanisole | 615-05-4 | ʼ91 |
4,4’-Diaminodiphenyl ether | 101-80-4 | ʼ91 |
2,4-Diaminotoluene | 95-80-7 | ʼ91 |
Diazinon | 333-41-5 | ʼ18 |
1,2-Dibromo-3-chloropropane | 96-12-8 | ʼ91 |
2,3-Dibromopropan-1-ol | 96-13-9 | ʼ01 |
p-Dichlorobenzene | 106-46-7 | ʼ91, (ʼ98) |
3,3’-Dichlorobenzidine | 91-94-1 | ʼ86 |
1,4-Dichloro-2-butene | 764-41-0 | ʼ15 |
3,3’-Dichloro-4,4’-diaminodiphenyl ether | 28434-86-8 | ʼ91 |
1,2-Dichloroethane | 107-06-2 | ʼ91 |
1,4-Dichloro-2-nitrobenzene | 89-61-2 | ʼ19 |
2,4-Dichloro-1-nitrobenzene | 611-06-3 | ʼ19 |
1,3-Dichloropropene (technical grade) | 542-75-6 | ʼ91 |
1,3-Dichloro-2-propanol | 96-23-1 | ʼ15 |
Dichlorvos | 62-73-7 | ʼ01 |
Diepoxybutane | 1464-53-5 | ʼ91 |
Diethanolamine | 111-42-2 | ʼ15 |
Di (2-ethylhexyl) phthalate | 117-81-7 | ʼ91 |
1,2-Diethylhydrazine | 1615-80-1 | ʼ91 |
Diglycidyl resorcinol ether | 101-90-6 | ʼ91 |
Diisopropyl sulfate | 2973-10-6 | ʼ95 |
N,N-Dimethylacetamide | 127-19-5 | ʼ19 |
p-Dimethylaminoazobenzene | 60-11-7 | ʼ91 |
2,6-Dimethylaniline | 87-62-7 | ʼ95 |
3,3’-Dimethylbenzidine (o-Tolidine) | 119-93-7 | ʼ91 |
1,1-Dimethylhydrazine | 57-14-7 | ʼ91 |
N,N-Dimethyl-p-toluidine | 99-97-8 | ʼ17 |
3,3’-Dimethoxybenzidine (o-Dianisidine) | 119-90-4 | ʼ86 |
2,4-(or 2,6-) Dinitrotoluene | 121-14-2 | ʼ98 |
1,4-Dioxane | 123-91-1 | ʼ86, (ʼ15) |
Disperseblue 1 | 2475-45-8 | ʼ91 |
DDT | 50-29-3 | ʼ86, (ʼ17) |
1,2-Epoxybutane | 106-88-7 | ʼ01 |
Ethyl acrylate | 140-88-5 | ʼ91, (ʼ19) |
Ethylbenzene | 100-41-4 | ʼ01, (ʼ20) |
2-Ethylhexyl acrylate | 103-11-7 | ʼ19 |
Ethyl methanesulphonate | 62-50-0 | ʼ91 |
Ethylene thiourea | 96-45-7 | ʼ86 |
Ethylenimine | 151-56-4 | ʼ01, (ʼ18) |
(2-Formylhydrazino)-4-(5-nitro-2-furyl) thiazole | 3570-75-0 | ʼ91 |
Furan | 110-00-9 | ʼ01 |
Furfuryl alcohol | 98-00-0 | ʼ19 |
Gasoline | 8006-61-9 | ʼ01 |
Glycidaldehyde | 765-34-4 | ʼ91 |
Glyphosate† | 1071-83-6 | ’21 |
Hexachlorocyclohexanes | 319-84-6 | ʼ91 |
HC blue No. 1 | 2784-94-3 | ʼ95 |
Heptachlor | 76-44-8 | ʼ01 |
Hexamethylphosphoramide | 680-31-9 | ʼ01 |
Isoprene | 78-79-5 | ʼ95, (ʼ17) |
Lead and compounds (except alkyl lead)* | 7439-92-1 | ʼ91, (ʼ16) |
Magenta (containing CI basic red 9) | 632-99-5 | ʼ95 |
Magnetic fields, extremely low-frequency | — | ʼ15 |
Malathion | 121-75-5 | ʼ18 |
Man-made mineral fibers (Ceramic fibers, Micro glass fibers) | — | ʼ91, ʼ03 |
Melamine | 108-78-1 | ʼ19 |
2-Mercaptobenzothiazole | 149-30-4 | ʼ19 |
4,4’-Methylene bis (2-methylaniline) | 838-88-0 | ʼ91 |
4,4’-Methylenedianiline | 101-77-9 | ʼ91, (ʼ95) |
Methyl isobutyl ketone | 108-10-1 | ʼ15 |
Methyl mercuries | 7439-97-6 | ʼ95 |
2-Methyl-1-nitroanthraquinone | 129-15-7 | ʼ91 |
N-Methyl-N-nitrosourethane | 615-53-2 | ʼ91 |
α-Methylstyrene | 98-83-9 | ʼ15 |
Mirex | 2385-85-5 | ʼ01 |
Molybdenum trioxide | 1313-27-5 | ʼ17 |
β-Myrcene | 123-35-3 | ʼ18 |
Naphthalene | 91-20-3 | ʼ15 |
Nickel compounds (except nickel carbonyl and nickel smelting dusts)* | 7440-02-0 | ʼ81, ʼ86, ʼ91, (ʼ09) |
2-Nitroanisole | 91-23-6 | ʼ98 |
4-Nitroanisole | 100-17-4 | ʼ19 |
Nitrobenzene | 98-95-3 | ʼ98 |
o-Nitrochlorobenzene | 88-73-3 | ʼ19 |
p-Nitrochlorobenzene | 100-00-5 | ʼ19 |
Nitrilotriacetic acid and its salts | 139-13-9 | ʼ91 |
Nitrogen mustard-N-oxide | 126-85-2 | ʼ91 |
5-Nitroacenaphtene | 602-87-9 | ʼ91 |
Nitromethane | 75-52-5 | ʼ01 |
2-Nitropropane | 79-46-9 | ʼ91 |
N-Nitrosodiethanolamine | 1116-54-7 | ʼ01 |
N-Nitroso-N-phenylhydroxylamine ammonium salt (Cupferron)† | 135-20-6 | ’21 |
N-Nitrosomorpholine | 59-89-2 | ʼ91 |
Oil orange SS | 2646-17-5 | ʼ91 |
PAHs (Benz[a]anthracene, Benz[j]aceanthrylene, Benzo[b]fluoranthene, Benzo[c]phenanthrene, Benzo[j]fluoranthene, Benzo[k]fluoranthene, Chrysene, Dibenz[a, h]acridine, Dibenz[c, h]acridine, Dibenzo[a, h]pyrene, Dibenzo[a, i]pyrene, 7H-Dibenzo[c, g]carbazole, 1,3-Dinitropyrene, 1, 6- Dinitropyrene, 1,8-Dinitropyrene, 5-Methylchrysene, 3-Nitrobenzanthrone, 4-Nitropyrene) | 56-55-3, 202-33-5, 205-99-2, 195-19-7, 205-82-3, 207-08-9, 218-01-9, 226-36-8, 224-53-3, 189-64-0, 189-55-9, 194-59-2, 75321-20-9, 42397-64-8, 42397-65-9, 3697-24-3, 17117-34-9, 57835-92-4 | ʼ16 |
Perfluorooctanoic acid | 335-67-1 | ʼ17 |
Phenyl glycidyl ether | 122-60-1 | ʼ91 |
o-Phenylenediamine and its dihydrochloride | 95-54-5, 615-28-1 | ʼ19 |
Polybrominated biphenyls | 59536-65-1 | ʼ91, (ʼ17) |
Polychlorophenols (technical grades) | — | ʼ86 |
Ponceau 3R | 3564-9-8 | ʼ91 |
Ponceau MX | 3761-53-3 | ʼ91 |
β-Propiolactone | 57-57-8 | ʼ91 |
Propylene imine (2-Methylaziridine) | 75-55-8 | ʼ91, (ʼ17) |
Propylene oxide | 75-56-9 | ʼ91, ʼ95 |
Pyridine | 110-86-1 | ʼ18 |
Quinoline | 91-22-5 | ʼ18 |
Radiofrequency electromagnetic fields | — | ʼ15 |
Styrene | 100-42-5 | ʼ91 |
1,1,2,2-Tetrachloroethane | 79-34-5 | ʼ15 |
Tetrachloroethylene | 127-18-4 | ʼ91, (ʼ01) |
Tetrafluoroethylene | 116-14-3 | ʼ01, (ʼ17) |
2,4,6-Trichlorophenol | 88-06-2 | ʼ18 |
Tetrabromobisphenol A | 79-94-7 | ʼ19 |
Tetrahydrofuran | 109-99-9 | ʼ19 |
Tetranitromethane | 509-14-8 | ʼ98 |
4,4’-Thiodianiline | 139-65-1 | ʼ91 |
Thiourea | 62-56-6 | ʼ95 |
Titanium dioxide | 13463-67-7 | ʼ15 |
Toluene diisocyanates (TDI) | 26471-62-5 | ʼ91 |
Trimethylolpropane Triacrylate (technical grade) | 15625-89-5 | ʼ19 |
Trypane blue | 72-57-1 | ʼ91 |
Urethane | 51-79-6 | ʼ91 |
Vanadium pentoxide | 1314-62-1 | ʼ15 |
Vinylidene chloride | 75-35-4 | ʼ18 |
Vinyl acetate | 108-05-4 | ʼ98 |
4-Vinylcyclohexene | 100-40-3 | ʼ95 |
4-Vinylcyclohexene diepoxide | 106-87-6 | ʼ95 |
*Evaluation does not necessarily apply to all individual chemicals within the group.
†Provisional
( ) in the year of proposal indicates year of reconsideration resulting in no classification change.
N,N-dimethylformamide is proposed to be excluded from Group 2B†
Only when scientifically reasonable information is available, JSOH will estimate a reference value corresponding to an individual excess lifetime risk of cancer due to exposure to a Group I carcinogen, and show it in Table III-2. JSOH does not recommend either the reference value as a safe exposure level or the individual excess lifetime risk as an acceptable risk level. The reference value should be applied only by experts well-trained and well-experienced in occupational health to avoid or minimize the risk of occupational cancer.
Substance | Individual excess lifetime risk of cancer | Reference value | Method of estimation | Year of estimation | |
---|---|---|---|---|---|
Arsenic and inorganic arsenic compounds | 10–3 | 3 | μg/m3 | Average relative risk model | ʼ00 |
10–4 | 0.3 | μg/m3 | |||
Asbestos | |||||
chrysotile | 10–3 | 0.15 | fibers/ml | Average relative risk model | ʼ00 |
10–4 | 0.015 | fibers/ml | |||
containing asbestos fibers | 10–3 | 0.03 | fibers/ml | ||
other than chrysotile | 10–4 | 0.003 | fibers/ml | ||
Benzene | 10–3 | 1 | ppm | Average relative risk model | ʼ97, (ʼ19) |
10–4 | 0.1 | ppm | |||
Ionizing radiation | (Table III-3) | ʼ12 | |||
Nickel smelting dusts (as Ni) | 10–3 | 10 | μg/m3 | Average relative risk model | ʼ09 |
10–4 | 1 | μg/m3 | |||
Vinyl chloride | 10–3 | 1.5 | ppm | Average relative risk model | ʼ17 |
10–4 | 0.15 | ppm |
The occupational carcinogens may have OEL in Table I-1. These values must be used with caution. Some substances had epidemiological or experimental evidences that carcinogenicity was observed only at significantly higher concentrations than those for non-carcinogenic health effects, but the others did not. For the latter case, the substance is indicated as ψ in Table I-13).
Table III-3 indicates reference values corresponding to an individual excess lifetime risk of cancer for ionizing radiation. A series of the reference values, i.e. unit risk doses of ionizing radiation, are shown as Radiation Exposure Induced Death (REID) levels of 100, 50, 10, 1 for 1,000 population with stratified by sex, age, and exposure situation (single, repeated). Dose and dose-rate effectiveness factor (DDREF) of 1 is being adopted primarily, and REID levels with DDREF of 2 are also calculated for comparison. The reference values here are calculated based on exposure-response relationship of low LET radiation, indicating that the values should not be applied in the case that internal exposure is considered.
Single exposure (mSV) DDREF=1 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | age at first exposure | REID | age at first exposure | |||||||||
18 | 28 | 38 | 48 | 58 | 18 | 28 | 38 | 48 | 58 | |||
10−1 | 892.2 | 1,075.5 | 1,342.1 | 1,760.8 | 2,441.8 | 10−1 | 762.9 | 939.2 | 1,204.2 | 1,628.9 | 2,320.5 | |
5×10−2 | 440.8 | 535.2 | 676.9 | 911.2 | 1,325.0 | 5×10−2 | 374.1 | 462.3 | 597.7 | 821.7 | 1,207.9 | |
10−2 | 87.4 | 106.8 | 136.7 | 189.0 | 291.6 | 10−2 | 73.7 | 91.4 | 119.0 | 166.0 | 251.9 | |
10−3 | 8.7 | 10.7 | 13.7 | 19.1 | 30.0 | 10−3 | 7.3 | 9.1 | 11.9 | 16.6 | 25.5 | |
10−4 | 0.9 | 1.1 | 1.4 | 1.9 | 3.0 | 10−4 | 0.7 | 0.9 | 1.2 | 1.7 | 2.6 | |
Repeated exposure until age 68 (from first exposure age to the end of age 67) (mSv/year) DDREF=1 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | age at first exposure | REID | age at first exposure | |||||||||
18 | 28 | 38 | 48 | 58 | 18 | 28 | 38 | 48 | 58 | |||
10−1 | 34.1 | 50.8 | 83.5 | 160.2 | 412.8 | 10−1 | 28.6 | 42.7 | 70.1 | 133.0 | 342.4 | |
5×10−2 | 16.4 | 24.5 | 40.3 | 77.5 | 203.9 | 5×10−2 | 13.8 | 20.7 | 33.9 | 64.5 | 167.5 | |
10−2 | 3.2 | 4.8 | 7.8 | 15.1 | 40.4 | 10−2 | 2.7 | 4.0 | 6.6 | 12.6 | 33.0 | |
10−3 | 0.3 | 0.5 | 0.8 | 1.5 | 4.0 | 10−3 | 0.3 | 0.4 | 0.7 | 1.3 | 3.3 | |
10−4 | 0.03 | 0.05 | 0.08 | 0.15 | 0.40 | 10−4 | 0.03 | 0.04 | 0.07 | 0.13 | 0.33 | |
Repeated 10 year exposure, (10 years from first exposure age) (mSv/year) DDREF=1 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | age at first exposure | REID | age at first exposure | |||||||||
18 | 28 | 38 | 48 | 58 | 18 | 28 | 38 | 48 | 58 | |||
10−1 | 101.7 | 126.8 | 168.1 | 245.8 | 412.8 | 10−1 | 85.5 | 108.2 | 145.3 | 211.0 | 342.4 | |
5×10−2 | 49.2 | 61.4 | 81.4 | 119.6 | 203.9 | 5×10−2 | 41.5 | 52.5 | 70.5 | 102.6 | 167.5 | |
10−2 | 9.6 | 12.0 | 15.9 | 23.4 | 40.4 | 10−2 | 8.1 | 10.3 | 13.8 | 20.1 | 33.0 | |
10−3 | 1.0 | 1.2 | 1.6 | 2.3 | 4.0 | 10−3 | 0.8 | 1.0 | 1.4 | 2.0 | 3.3 | |
10−4 | 0.10 | 0.12 | 0.16 | 0.23 | 0.40 | 10−4 | 0.08 | 0.10 | 0.14 | 0.20 | 0.33 | |
Repeated 5 year exposure, (5 years from first exposure age) (mSv/year) DDREF=1 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | age at first exposure | REID | age at first exposure | |||||||||
18 | 28 | 38 | 48 | 58 | 18 | 28 | 38 | 48 | 58 | |||
10−1 | 192.5 | 236.8 | 306.4 | 430.4 | 673.3 | 10−1 | 161.8 | 202.3 | 266.4 | 376.7 | 581.4 | |
5×10−2 | 93.3 | 115.0 | 149.3 | 211.4 | 337.9 | 5×10−2 | 78.6 | 98.3 | 129.7 | 184.1 | 287.1 | |
10−2 | 18.2 | 22.5 | 29.3 | 41.7 | 68.0 | 10−2 | 15.4 | 19.2 | 25.4 | 36.2 | 56.9 | |
10−3 | 1.8 | 2.2 | 2.9 | 4.2 | 6.8 | 10−3 | 1.5 | 1.9 | 2.5 | 3.6 | 5.7 | |
10−4 | 0.18 | 0.22 | 0.29 | 0.42 | 0.68 | 10−4 | 0.15 | 0.19 | 0.25 | 0.36 | 0.57 | |
Single exposure (mSv) DDREF=2 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | Age 18 | 28 | 38 | 48 | 58 | REID | Age 18 | 28 | 38 | 48 | 58 | |
10−1 | 1,541.0 | 1,801.1 | 2,139.4 | 2,599.6 | 3,245.9 | 10−1 | 1,403.1 | 1,692.1 | 2,084.0 | 2,646.2 | 3,436.8 | |
5×10−2 | 797.0 | 946.9 | 1,153.4 | 1,455.7 | 1,911.2 | 5×10−2 | 707.5 | 862.9 | 1,085.7 | 1,425.2 | 1,940.6 | |
10−2 | 165.1 | 199.8 | 251.4 | 335.9 | 486.3 | 10−2 | 142.8 | 176.1 | 226.6 | 309.8 | 453.4 | |
10−3 | 16.7 | 20.3 | 25.8 | 35.1 | 53.3 | 10−3 | 14.3 | 17.7 | 22.9 | 31.7 | 47.7 | |
10−4 | 1.7 | 2.0 | 2.6 | 3.5 | 5.4 | 10−4 | 1.4 | 1.8 | 2.3 | 3.2 | 4.8 | |
Repeated exposure until age 68 (from first exposure age to the end of age 67) (mSv/year) DDREF=2 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | age at first exposure | REID | age at first exposure | |||||||||
18 | 28 | 38 | 48 | 58 | 18 | 28 | 38 | 48 | 58 | |||
10−1 | 63.5 | 93.4 | 150.2 | 276.5 | 650.5 | 10−1 | 54.9 | 81.4 | 131.9 | 244.7 | 596.9 | |
5×10−2 | 30.7 | 45.3 | 73.2 | 136.8 | 337.3 | 5×10−2 | 26.6 | 39.5 | 64.2 | 120.1 | 301.3 | |
10−2 | 6.0 | 8.8 | 14.4 | 27.2 | 70.2 | 10−2 | 5.2 | 7.7 | 12.6 | 23.7 | 60.9 | |
10−3 | 0.6 | 0.9 | 1.4 | 2.7 | 7.1 | 10−3 | 0.5 | 0.8 | 1.3 | 2.4 | 6.1 | |
10−4 | 0.06 | 0.09 | 0.14 | 0.27 | 0.71 | 10−4 | 0.05 | 0.08 | 0.13 | 0.24 | 0.61 | |
Repeated 10 year exposure, (10 years from first exposure age) (mSv/year) DDREF=2 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | age at first exposure | REID | age at first exposure | |||||||||
18 | 28 | 38 | 48 | 58 | 18 | 28 | 38 | 48 | 58 | |||
10−1 | 191.2 | 235.3 | 304.2 | 424.7 | 650.5 | 10−1 | 165.2 | 207.5 | 274.3 | 387.7 | 596.9 | |
5×10−2 | 93.2 | 115.1 | 149.9 | 212.5 | 337.3 | 5×10−2 | 80.5 | 101.2 | 134.4 | 191.7 | 301.3 | |
10−2 | 18.3 | 22.6 | 29.7 | 42.6 | 70.2 | 10−2 | 15.8 | 19.9 | 26.5 | 38.0 | 60.9 | |
10−3 | 1.8 | 2.3 | 3.0 | 4.3 | 7.1 | 10−3 | 1.6 | 2.0 | 2.6 | 3.8 | 6.1 | |
10−4 | 0.18 | 0.23 | 0.30 | 0.43 | 0.71 | 10−4 | 0.16 | 0.20 | 0.26 | 0.38 | 0.61 | |
Repeated 5 year exposure, (5 years from first exposure age) (mSv/year) DDREF=2 | ||||||||||||
(a) Male | (b) Female | |||||||||||
REID | age at first exposure | REID | age at first exposure | |||||||||
18 | 28 | 38 | 48 | 58 | 18 | 28 | 38 | 48 | 58 | |||
10−1 | 358.0 | 433.6 | 545.5 | 726.9 | 1,032.7 | 10−1 | 310.9 | 385.1 | 497.8 | 681.2 | 989.7 | |
5×10−2 | 176.0 | 214.5 | 272.8 | 371.6 | 550.8 | 5×10−2 | 152.1 | 189.1 | 246.1 | 341.5 | 510.3 | |
10−2 | 34.8 | 42.6 | 54.7 | 76.1 | 118.5 | 10−2 | 29.9 | 37.3 | 48.8 | 68.6 | 105.3 | |
10−3 | 3.5 | 4.3 | 5.5 | 7.7 | 12.1 | 10−3 | 3.0 | 3.7 | 4.9 | 6.9 | 10.6 | |
10−4 | 0.35 | 0.42 | 0.55 | 0.77 | 1.21 | 10−4 | 0.30 | 0.37 | 0.49 | 0.69 | 1.06 |
This table is the list of occupational sensitizers to the airway and skin (Table IV). The sensitizers are classified into Group 1 substances which induce allergic reactions in humans, Group 2 substances which probably induce allergic reactions in humans, and Group 3 substances which are considered possibly to induce allergic reactions in humans based on animal experiments.
Airway |
Group 1 |
Beryllium*, Cobalt*, Colophony (Rosin)*, Diphenylmethane-4,4’-diisocyanate (MDI), Glutaraldehyde, Hexane-1,6-diisocyanate, Methyltetrahydrophthalic anhydride, o-Phthalaldehyde†, Phthalic anhydride, Platinum*, Toluene diisocyanates*, Trimellitic anhydride |
Group 2 |
Chlorothalonil, Chromium*, Ethylenediamine, Formaldehyde, Maleic anhydride, Methyl methacrylate, Nickel*, Piperazine |
Skin |
Group 1 |
Aniline, Benzoyl peroxide, Benzyl alcohol, Chlorothalonil, Chromium*, Cobalt*, Colophony (Rosin)*, 2,4-Dinitrochlorobenzene (DNCB), Epichlorohydrin, Formaldehyde, Glutaraldehyde, Hydrazine*, Mercury*, Methacrylic acid 2-hydroxyethyl ester (2-Hydroxyethyl methacrylate), 4,4’-Methylenedianiline, Nickel*, p-Phenylenediamine, o-Phthalaldehyde†, Platinum*, Resorcinol, Sodium ethylmercury 2-Sulfidobenzoate (Thimerosal), Thiuram, Trichloroethylene, Tri (propylene glycol) diacrylate, N,N’,N’’-Tris (β-hydroxyethyl)-hexahydro-1,3,5-triazine, Turpentine*, m-Xylylendiamine |
Group 2 |
Acrylamide, Benomyl, Benzyl alcohol, Beryllium*, Buthyl acrylate, N-butyl-2,3-epoxy-propyl ether, Copper*, Dibutyl phthalate, Dichloropropane, Dicyclohexylcarbodiimide, Diethanolamine, 2,3-Epoxypropyl methacrylate (Glycidyl methacrylate, GMA), Ethyl acrylate, Ethylenediamine, Ethylene glycol dimethacrylate†, Ethylene oxide, 1,6-Hexanediol diacrylate†, Hydroquinone, 2-Hydroxyethyl methacrylate, Iodine*, Maleic anhydride, Methyl acrylate, Methyl methacrylate, Picric acid, Polyvinyl chloride plasticizers*, Rodium*, Toluene diamine*, Toluene diisocyanates*, Usnic acid |
Group 3 |
m-Chloroaniline, Dimethylamine, Isophoronediisocyanate, o-Phenylenediamine, m-Phenylenediamine |
*Evaluation does not necessarily apply to all individual chemicals within the group. †Provisional.
The revised definition of “Occupational sensitizer” has been applied to the substances proposed in 1998 or later, and the substances listed before 1998 are not fully re-examined at this time; please note that OEL values are not necessarily recommended to all the substances listed here. See JSOH web site for brief summary of OEL documentation at http://sanei.or.jp/oel-eng
Recommendation of occupational exposure limits for the occupational sensitizers does not necessarily consider either prevention of sensitization or allergic reaction. Any substance which is not included in the list does not indicate that the substance is not a sensitizer.
The Japan Society for Occupational Health (JSOH) classifies reproductive toxicants on the basis of evidence of reproductive toxicity obtained from epidemiological studies and other studies in humans, as well as that from experimental studies in animals. The classification is made based on the strength of the evidence for adverse effects on reproduction in humans, but does not reflect the potency of such adverse effects. Namely, the classification does not necessarily indicate that exposures to the classified substances at the present Occupational Exposure Limit (OEL-M) levels induce adverse effects on reproduction. The definition of reproductive toxicity and the classification criteria for judgment are as follows.
1. Definition of reproductive toxicityReproductive toxicity includes adverse effects on reproductive functions in males and females, as well as on the offspring. Effects on functions such as fertility, pregnancy, delivery, and lactation in women, and fertility/insemination in men are within the scope of the definition. Substances that have adverse effects on reproductive organs are also included within the classification criteria if it is suspected that the reproductive functions referred to above are affected. In the case of offspring, reproductive toxicity is defined as the effects on the development of the embryo/fetus including teratogenic insults by prenatal exposure to the substance and/or the effects on the infant by postnatal exposure via lactation due to transfer in breast milk. If effects on post-weaning growth, behavior, function, sexual maturation, carcinogenesis, accelerated aging, and other processes are clearly demonstrated in the offspring as a result of parental exposure, then such effects are considered as reproductive toxicity.
2. Classification and judgment criteria1) Classification of reproductive toxicants:
Reproductive toxicants shall be classified in Group 1, Group 2, or Group 3, defined as follows.
Group 1: Substances known to cause reproductive toxicity in humans.
Group 2: Substances presumed to cause reproductive toxicity in humans.
Group 3: Substances suspected to cause reproductive toxicity in humans.
2) Judgment criteria for the classification of reproductive toxicity:
Group 1: Substances for which sufficient evidence in humans has been obtained from epidemiological studies and other human studies shall be classified.
Sufficient evidence that demonstrates reproductive toxicity in humans is required, where sufficient means two or more reports of epidemiological studies conducted in an appropriate manner. A single epidemiological study can be used as the evidence for classification to this group if any of the following conditions are satisfied: a) the study takes into consideration both dose-response relationships and co-exposure to other substances or potential confounding factors, in an appropriate manner; b) the study is supported by many non-epidemiological study reports on, for example, clinical cases or accidental exposures, indicating reproductive toxicity and it can therefore be decided overall that there is sufficient evidence of toxicity in humans. Animal experimental data are considered as supportive information.
Group 2: Substances for which sufficient evidence demonstrating reproductive toxicity has been obtained in appropriate animal experiments, and thus presumed to cause reproductive toxicity in humans, shall be classified.
Judgment shall be made on the basis of animal experiments, namely, evidence showing obvious adverse effects on reproduction in animals, identified by appropriately conducted animal experimental studies, and thus reasonably indicating that the substance causes reproductive toxicity in humans. When judgment is made from the results of animal experiments, it is required that the observed effects should not be the consequences of secondary non-specific effects of other general toxicities, and that the identified mechanism of action be non-species-specific and therefore relevant for extrapolation to humans. In addition, if the observed changes are small and exert only non-significant effects on the life or function of the subject, then such changes are considered as not satisfying the requirement.
Group 3: Substances for which limited evidence has been demonstrated shall be classified.
Substances are allocated into this group when reproductive toxicities are suspected from reports in humans or from animal experiments. If information for reproductive toxicity is obtained from epidemiological studies, other human studies, and/or animal experiments, but such evidence is not considered to be sufficient for allocating the substance to Group 1 or Group 2, then classification in Group 3 should be considered.
3. Classified reproductive toxicantsTable V. lists the substances classified in each reproductive toxicant group according to the judgment criteria referred to above. The judgment is made for substances for which OEL is recommended by JSOH based on information described in the documentation for Recommendation of Occupational Exposure Limits by JSOH and other relevant information; this does not mean that substances not included in the table do not meet the classification criteria of reproductive toxicity. There may be some substances for which reproductive toxicity might be observed below the level of OEL-M or OEL-B; in such cases, precautionary notice is given by adding a symbol (#) next to the substances in Table V.
Group 1 |
Arsenic and compounds, 2-Bromopropane, Cadmium and compounds, Carbon disulfide, Carbon monoxide#, Di (2-ethylhexyl) phthalate#, Ethylene glycol monomethyl ether, Ethylene glycol monomethyl ether acetate, Ethylene oxide, Lead and compounds#, Perfluorooctanoic acid (PFOA)#, Polychlorobiphenyls (PCB), Toluene |
Group 2 |
Acrylamide, Benomyl#, 1-Bromopropane, Chlorodifluoromethane, Chloromethane, 2,4-Dichlorophenoxyacetic acid (2,4-D), N,N-Dimethylacetamide, N,N-Dimethylformamide (DMF), Ethyl benzene, Ethylene glycol monobutyl ether, Ethylene glycol monoethyl ether, Ethylene glycol monoethyl ether acetate, Inorganic mercury (including mercury vapor), Manganese and its compounds (as Mn except organic manganese compounds), Methanol, Pentachlorophenol (PCP), Styrene, Vanadium and compounds, Xylene for industrial use |
Group 3 |
Atrazine, n-Butyl-2,3-epoxypropylether, Chromium and compounds, p-Dichlorobenzene, 2,3-Epoxypropyl methacrylate (Glycidyl methacrylate, GMA), Ethyleneimine, 2-Ethyl-1-hexanol, Ethylidene norbornene, Glyphosate†, Nickel and compounds, Phenol, Tetrachloroethylene, Trichloroethylene, Xylene (ortho-, meta-, para-xylene and their mixture) |
Not all substances that may exert reproductive toxicity are identified.
#: Precaution should be given for lower exposure than OEL-M or OEL-B. As for reproductive toxicity, it is generally known that there is a sensitive period, during pregnancy for example, and such effects of this substance have been identified.
†Provisional
See JSOH web site for brief summary of OEL documentation at http://sanei.or.jp/oel-eng
Occupational exposure limits (OELs) for continuous or intermittent noise exposure are recommended as follows to protect against noise-induced hearing loss.
1. OELs for continuous or intermittent noiseValues in Fig. VI or Table VI-1 show OELs, at or below which noise-induced permanent threshold shift (NIPTS) is expected to be below 10 dB at or below a frequency of 1 kHz, below 15 dB at 2 kHz, and below 20 dB at or more than 3 kHz after more than 10 years of continuous or intermittent noise exposure for 8 hours a day in most workers.
Occupational exposure limits for continuous or intermittent noise.
Center frequency (Hz) | OELs by octave-band level (dB) | |||||
---|---|---|---|---|---|---|
480 min | 240 min | 120 min | 60 min | 40 min | 30 min | |
250 | 98 | 102 | 108 | 117 | 120 | 120 |
500 | 92 | 95 | 99 | 105 | 112 | 117 |
1000 | 86 | 88 | 91 | 95 | 99 | 103 |
2000 | 83 | 84 | 85 | 88 | 90 | 92 |
3000 | 82 | 83 | 84 | 86 | 88 | 90 |
4000 | 82 | 83 | 85 | 87 | 89 | 91 |
8000 | 87 | 89 | 92 | 97 | 101 | 105 |
OELs can be applied to wide and narrow-band noise with band width below 1/3 octave. OELs are temporarily applicable to pure tones regarded as narrow-band noise. Impulsive or impact noise is excluded from the application (see Section VII).
3. Application method(1) In the case of continuous noise exposure throughout the work-time, OELs corresponding to the exposure duration should be taken from Fig. VI or Table VI-1.
(2) In the case of intermittent noise exposure, an equivalent exposure duration is considered to be the sum of exposure duration throughout the work-time minus an effective resting duration, and OELs corresponding to the equivalent exposure duration should be taken from Fig. VI or Table VI-1. The effective resting duration is the duration when the noise levels are below 80 dB.
(3) In the case that noise is analyzed by an octave band filter, OELs corresponding to exposure duration are the values at the left ordinate of Fig. VI or in Table VI-1. In the case that noise is analyzed by a narrower band filter with a band width of 1/3 octave or less, OELs are the values at the right ordinate of Fig. VI or the values subtracted 5 from the figures in Table VI-1.
4. OELs by A-weighted sound pressure levelBasically, frequency analysis of noise is recommended. In the case of evaluating with an A-weighted sound pressure level, OELs in Table VI-2 should be used.
Exposure duration (hours-minutes) | OELs by A-weighted sound pressure level (dB) | Exposure duration (hours-minutes) | OELs by A-weighted sound pressure level (dB) |
---|---|---|---|
24−00 | 80 | 2−00 | 91 |
20−09 | 81 | 1−35 | 92 |
16−00 | 82 | 1−15 | 93 |
12−41 | 83 | 1−00 | 94 |
10−04 | 84 | 0−47 | 95 |
8−00 | 85 | 0−37 | 96 |
6−20 | 86 | 0−30 | 97 |
5−02 | 87 | 0−23 | 98 |
4−00 | 88 | 0−18 | 99 |
3−10 | 89 | 0−15 | 100 |
2−30 | 90 |
For measurement methods, refer to ‘Japan Industrial Standard (JIS) Z 8731–1999 Acoustics-Description and measurement of environmental noise’.
Occupational Exposure Limits (OELs) for impulsive or impact noise exposure in the workplace are recommended as follows to protect against noise-induced hearing loss.
1. OELs for impulsive or impact noiseIn the case that total frequency of exposure to impulsive or impact noise is at or below 100 times a day, the peak sound pressure level shown in Fig. VII-1 is recommended as the OEL corresponding to the duration of impulsive or impact noise explained in “3. Measurement method”.
In the case that total number of exposures to impulsive or impact noise is above 100 times a day, the sum of the peak sound pressure level in Fig. VII-1 with the adjustment value in Fig. VII-2 to cerrect the difference of exposure frequency is recommended as OEL. At or below these limits, NIPTS is expected to be below 10 dB at or below a frequency of 1 kHz, below 15 dB at 2 kHz, and below 20 dB at or more than 3 kHz after more than 10 years of impulsive or impact noise exposure in most workers.
Occupational exposure limits for impulsive or impact noise.
Correction values corresponding to exposure frequency a day.
These OELs are applicable to impulsive or impact noise only. In the case of mixed exposure to both impulsive or impact noise and continuous or intermittent noise, both OELs should be satisfied.
3. Measurement methodImpulsive or impact noises are classified by their oscilloscope-measured wave forms into two groups, as shown in Fig. VII-3 (A) and (B). In Fig. VII-3 (A), A duration is defined as the duration between TO and TD. In Fig. VII-3 (B), B duration is defined as either the duration between T0 and TD’ if no reflection sound exists, or the sum of durations between T0 and TD’ and between T0’’ and TD’’ if reflection sound dose exists. In the case of (B), TD’ or TD’’ is determined by the intersection of a wave envelope indicating sound pressure change with a line indicating a sound pressure 20 dB below peak sound pressure. This method is also applicable in the case of multiple reflection sounds.
Measurement for impulsive or impact noise.
In the case that total frequency of exposure to impulsive or impact noise is at or below 100 times a day, OEL is 120 dB at A-weighted sound pressure level. In the case that total frequency of exposure to impulsive or impact noise is above 100 times a day, the adjustment value in Fig. VII-2 corresponding to frequency of exposure should be added for OEL determination.
2. ApplicationOEL is applicable to type B wave in Fig. VII-3 only.
3. Measurement methodMaximum values should be measured by the Sound Level Meter (JIS C 1509-1-2005) with use of an A-weighted frequency response and fast dynamic characteristic.
Permissible heat exposure limits were proposed as Table VIII-1 on the presumption that any unfavorable physiological response should not be caused by the heat stress.
Work load | OELs |
---|---|
WBGT (°C) | |
RMR ~1 (Very Light, ~130 kcal/h) | 32.5 |
RMR ~2 (Light, ~ 190 kcal/h) | 30.5 |
RMR ~3 (Moderate, ~ 250 kcal/h) | 29.0 |
RMR ~4 (Moderate, ~ 310 kcal/h) | 27.5 |
RMR ~5 (Heavy, ~ 370 kcal/h) | 26.5 |
These exposure limits show the condition for which the workers work without health impairment or decrease in work efficiency for one hour of continuous work or two hours of intermittent work. The workers mentioned here are healthy adult male workers, adapted themselves to hot environment, well used to the work, wearing usual summer clothes, and taking enough water and salt.
Hot environment means the condition in which the regulation of body temperature is mainly performed by the evaporation responding to the complex of ambient temperature, humidity, and heat radiation.
Adaptation is the effect of the vicarious physiological change of the worker working under hot environment.
The thermal adaptation is obtained by usually working for one week under hot environment. If hot environment exposure is ceased, the adaptation effect is lost immediately and usually disappears in two weeks. Therefore, it is necessary to pay attention to the workers’ condition when their adaptation is not enough or when they return to work after two or more days off.
The unfavorable physiological response is the state that physiological burdens such as increase of the heart rate, a rise in temperature, the increase of the quantity of water loss continue increasing.
Therefore, if the physiological burden on worker continues increasing under hot environment, some engineering measures should be taken or other measures like wearing cool clothes and reducing work load should be performed to decrease heat strain. The heat stress consists of factors such as environmental thermal condition, heat production through metabolism and heat exposure time.
The work load means metabolic energy used at the work. We expressed the degree in Relative Metabolic Rate (RMR) and classified in five categories as shown in Table VIII-2. RMR is calculated by the following expression.
Work load | Metabolic energy (kcal/h) |
---|---|
RMR ~1 (Very Light, ~130 kcal/h) | ~130 |
RMR ~2 (Light, ~ 190 kcal/h) | ~190 |
RMR ~3 (Moderate, ~ 250 kcal/h) | ~250 |
RMR ~4 (Moderate, ~ 310 kcal/h) | ~310 |
RMR ~5 (Heavy, ~ 370 kcal/h) | ~370 |
RMR values according to common movements are displayed in Table VIII-3. This table should be referred to estimate the work load.
RMR | Principal motion sites | Motion | Examples of works |
---|---|---|---|
0−0.5 0.5−1.0 | hand | moving mechanically | call handling (seated) 0.4, data entry 0.5, gauge monitoring (seated) 0.5, |
moving consciously | straightening (hammer tapping, 98 times/min) 0.9, vehicle driving 1.0 | ||
1.0−2.0 2.0−3.0 | hand movement with some upper limb movement | hand movement with some forearm movement forearm | lathe work (pairing, 0.83 minutes/unit) 1.1, surveillance work (standing) 1.2, walking slowly on level ground (45 m/min) 1.5 |
hand movement with some upper arm movement | walking (ordinary, 71 m/min) 2.1, concrete polishing (lightly) 2.0, circular saw work 2.5, stair walking (down, 50 m/min) 2.6 | ||
3.0−4.0 | upper limb | normal movement | chinning grinder (grinding 150 kg parts, 6 min. / unit) 3.0, riding bicycle (level ground, 170 m/min) 3.4, walking (fast, 95 m/min) 3.5 |
4.0−5.5 | relatively big movement with power | riveting (1.3 /min) 4.2, filing (36 cm file, 150 times /min.) 4.2, rough saw 5.0 | |
5.5−6.5 | whole body lifting, turning, pulling, pushing, throwing, moving up-and-down, scraping | normal movement | tapping (poking 7 kg, 16-20 times/min) 5.7, shoveling (6 kg, 18 times/min) 6.5, stair walking (up, 45 m/min) 6.5 |
6.5−8.0 | relatively big movement with equal power especially momentary | hammering (6.8 kg, 26 times/min.) 7.8 | |
8.0−9.5 | pile up (15 kg, 10 times/min) 9.0 | ||
10.0− 12.0 | whole body (same as above) | physically strenuous work with a bit of leeway; may continue for sometime | pushing at full power 10.0 pickaxe (concrete bursts) 10.5 shovel (72 times/min.) 11.0 |
12.0− | physically strenuous work such as construction work | concentrate on whole body movement and can tolerate only for less than one minute | hammering (4.5 kg, 29 times/min) 19.3 |
In an ordinary industrial setting, many of the works are manually performed continuously with the work load of around RMR 1.0. And most of the work loads are not more than RMR 2. However, it is considered possible to work continuously for one hour by the work load of RMR 4, we set one hour continuous work as the basic work unit for the work load up to RMR 4. Furthermore, although the work exceeding RMR 4 may exist, we assumed those work must be performed intermittently, as it is difficult to continue for one hour.
Therefore, regarding the working hour mentioned here, we classify the work into continuous work or intermittent work. We assumed one-hour work as the evaluation unit for continuous work and proposed the method of evaluating the environment in one-hour continuous work for normal eight hours. Likewise, we assumed two-hour work as the evaluation unit for intermittent work and proposed the method of evaluating the environment in two-hour intermittent work similarly. We adopted these methods in order to make it applicable to the real industrial workshop and to make it possible to evaluate in a short time.
3. Thermal index and method for measuring workloadWe decided to use the environmental index corresponding to the physiological response by the heat stress for an evaluation of the hot environment. As the best method now, we adopted Wet Bulb Globe Temperature (WBGT) as the simple and practical index for the thermal condition.
Calculation of thermal index
Methods for the measurement of thermal index are described elsewhere. WBGT is calculated as follows.
Calculation of WBGT
(1) Inside the room or outdoors without sunlight radiation
WBGT = 0.7NWB + 0.3GT
(2) Outdoors with sunlight radiation
WBGT = 0.7NWB + 0.2GT + 0.1DB
NWB (natural wet bulb temperature): Wet bulb temperature (without breathing forcibly and not surrounding the bulb part to prevent heat radiation) measured with being exposed to natural air flow
GT (globe thermometer temperature): Temperature measured by globe thermometer of 6 inches in diameters
DB (dry bulb temperature): Dry bulb temperature measured by covering the bulb part to prevent the direct effect of heat radiation without interfering spontaneous air flow
At measurement, it is important to comprehensively evaluate the thermal load affected by the ambient thermal condition and artificial heat production in the workplace. The actual situation including the workers’ condition should be fully understood such as the work position, the work intensity, the time and frequency of the heat exposure. We estimate the actual work condition as follows.
In the case of continuous work, the thermal condition of the workplace should be defined as the highest one-hour value of WBGT in a daily working hour.
In the case of two-hour intermittent work, the thermal condition of the workplace should be defined by two-hour time-weighted value of WBGT.
Two-hour time-weighted value of WBGT = (WBGT1 × t1 + WBGT2 × t2 +... + WBGTn × tn) /120 minutes WBGT1, WBGT2... WBGTn: Each value of WBGT at work or at break
t1, t2... tn: Each value of time at work or at break (minute)
The method to calculate work load of two-hour intermittent work is as follows.
If the workers are engaged in heavy/moderate work load for more than one hour, we define it as moderate workload.
If the workers are engaged in light work load for more than one hour, and the rest in moderate workload, we define it as light work load.
If the workers are engaged in light work load for more than one hour, and the rest in heavy workload, we define it as moderate work load.
When each of the work load is of concern, we calculate the two-hour load average of the work load as follows.
Two-hour load average of the work load = (WL1 × t1 + WL2 × t2 + … + WLn × tn) /120 minutes
WL1, WL2 … WLn: Each value of work load at each work or at break
t1, t2... tn: Each time at work or at break (minute)
4. Year of proposal: 1982Workers should wear appropriate clothing to protect themselves from cold stress in cold environments. The values of thermal insulation of the combination of clothing are shown in Table IX-1.
Combination of clothing | clo value |
Underwear (top /bottom), shirt, trousers, coat, vest, socks, shoes | 1.11 |
Underwear (top /bottom), thermal jumper, thermal trousers, socks, shoes | 1.40 |
Underwear (top /bottom), shirt, trousers, coat, over jacket, cap, gloves, socks, shoes | 1.60 |
Underwear (top /bottom), shirt, trousers, coat, over jacket, over trousers, socks, shoes | 1.86 |
Underwear (top /bottom), shirt, trousers, coat, over jacket, over trousers, cap, gloves, socks, shoes | 2.02 |
Underwear (top /bottom), over jacket, over trousers, thermal jumper, thermal trousers, socks, shoes | 2.22 |
Underwear (top /bottom), over jacket, over trousers, thermal jumper, thermal trousers, cap, gloves, socks, shoes | 2.55 |
Cold protective clothing | 3~4.5 |
Sleeping bag | 3~8 |
Recommendations about clothing: Wear several layers of loose clothing. Layering provides better insulation. Make sure to protect the ears, face, hands, and feet in extremely cold weather. Boots should be waterproof and insulated. Avoid touching cold metal surfaces with bare skin.
The gloves are necessary to prevent frostbite of the hands. The appropriate gloves should be chosen, depending on work, and waterproof gloves in some cases. If the degree of the chilliness is severer, mittens are more effective.
The relationship between equivalent temperature and thermal insulation of clothing, during both light and moderate workloads is presented in Table IX-2.
Temperature | Work load | Maximal work duration (min) |
---|---|---|
−10~–25°C | Light work (RMR~2) | ~ 50 |
Moderate work (RMR~3) | ~ 60 | |
−26~–40°C | Light work (RMR~2) | ~ 30 |
Moderate work (RMR~3) | ~ 45 | |
−41~–55°C | Light work (RMR~2) | ~ 20 |
Moderate work (RMR~3) | ~ 30 |
When air temperature is lower, the worker should wear clothing with higher thermal insulation power. And also, when a workload is low, the worker should wear higher thermal insulation clothing, because the internal heat produced by the body is lower than in the case of a higher workload.
In the cold environment, the wind velocity becomes a critical factor as well as air temperature.
An equivalent chill temperature chart relating the air temperature and the wind velocity is presented in Table IX-3.
wind velocity (m/sec) | air temperature (°C) | ||||||||||
0 | −5 | −10 | −15 | −20 | −25 | −30 | −35 | −40 | −45 | −50 | |
equivalent chill temperature (°C) | |||||||||||
calm | 0 | −5 | −10 | −15 | −20 | −25 | −30 | −35 | −40 | −45 | −50 |
2 | −1 | −6 | −11 | −16 | −21 | −27 | −32 | −37 | −42 | −47 | −52 |
3 | −4 | −10 | −15 | −21 | −27 | −32 | −38 | −44 | −49 | −55 | −60 |
5 | −9 | −15 | −21 | −28 | −34 | −40 | −47 | −53 | −59 | −66 | −72 |
8 | −13 | −20 | −27 | −34 | −41 | −48 | −55 | −62 | −69 | −76 | −83 |
11 | −16 | −23 | −31 | −38 | −46 | −53 | −60 | −68 | −75 | −83 | −90 |
15 | −18 | −26 | −34 | −42 | −49 | −57 | −63 | −73 | −80 | −88 | −96 |
20 | −20 | −28 | −36 | −44 | −52 | −60 | −68 | −76 | −84 | −92 | −100 |
Maximum work period recommended for properly clothed workers, working 4-hour shifts, at air temperatures and workloads are shown in Table IX-4. The workload is expressed in RMR (Relative Metabolic Rate) with the identical case of occupational exposure limits for heat stress. Light workload is less than RMR 2, (less than 190 kca1/h, metabolic energy), and moderate workload is RMR 2-3 (about 250 kca1/h, metabolic energy).
Air temperature | Work lord | Maximum work period (min) | |
---|---|---|---|
−10~−25°C | light work lord. | (RMR~2) | ~50 |
moderate work load | (RMR~3) | ~60 | |
−26~−40°C | light work load | (RMR~2) | ~30 |
moderate work load | (RMR~3) | ~45 | |
−41~−55°C | light workload | (RMR~2) | ~20 |
moderate work load | (RMR~3) | ~30 |
Wind velocity is below 0.5 m/sec, in an almost windless environment.
The standard work conditions are for four hours by shift work taking a rest in a recovery room for at least 30 minutes after one work sequel to.
There is much continuous light work (RMR l-2) and moderate work of RMR 3 in some cases. In the workload of these levels, physical loads to thermoregulation system by the cold stress, are bigger than the load to breathing and the circulatory system in the body function by the work.
The standard work conditions are for four hours shift work, taking a rest for at least 30 minutes after each shift work, wearing adequate cold-protective clothing to work in an almost windless environment.
Physical effects by cold chill index and equivalent temperature are shown in Table IX-5.
Cold chill index | Equivalent air temperature (°C) | Physical effects |
---|---|---|
1,000 | −14 | Very cold |
1,200 | −22 | Extremely cold |
1,400~1,550 | −30~−38 | Frostbite of exposed skin in one hour |
1,700~1,900 | −45~−53 | Dangerous outside activity such as walking, frostbite occurs on exposed part of the face in one minute |
2,000~2,300 | −61~−69 | Frostbite occurs on exposed part of the face in 30 seconds |
In cold environments, skin temperatures decrease particularly in the tip of the hands and feet. Body temperatures decrease, when heat production in the body is less than the heat radiation on the equilibrium of the internal heat balance.
Tremors and unconsciousness appear by hypothermia. Core temperature such as rectal temperature should keep above 36°C. Outbreak of more intense tremors is the danger signal that temperature is decreasing more, and one should promptly stop exposure to the cold.
Work efficiency decreases and is unsafe due to pain, tightening, and the chilliness of the peripheral parts such as hands and feet. Furthermore, the skin temperature of the toes is approximately 13°C, and 10°C at the fingers. Pain and numbness by cold is a danger signal leading to frostbite.
0.35 m/s2Asum (8)
Occupational exposure limits for hand-arm vibration using vibration total value of frequency-weighted r.m.s. acceleration.
Exposure time (min) | Vibration total value of frequency-weighted r.m.s. acceleration (m/s2 r.m.s.) |
---|---|
≤6 | 25.0 |
10 | 19.4 |
15 | 15.8 |
30 | 11.2 |
60 | 7.92 |
90 | 6.47 |
120 | 5.60 |
150 | 5.01 |
180 | 4.57 |
210 | 4.23 |
240 | 3.96 |
270 | 3.73 |
300 | 3.54 |
330 | 3.38 |
360 | 3.23 |
390 | 3.11 |
420 | 2.99 |
450 | 2.89 |
480 | 2.80 |
OEL-M | OEL-C | |
---|---|---|
Head, trunk | 200 mT (1.63×105 Am–1) | 2T |
Extremities | 500 mT (4.08×105 Am–1) | 5T |
Frequency (f) | EF* | Magnetic flux density | MF† |
---|---|---|---|
0.25~1.0 Hz | 50/f mT | 4.08 × 104/f Am−1 | |
1.0~25 Hz | 20 kVm−1 | 50/f mT | 4.08 × 104/f Am−1 |
25~500 Hz | 500/f kVm−1 | 50/f mT | 4.08 × 104/f Am−1 |
500~814 Hz | 500/f kVm−1 | 0.1 mT | 81.4 Am−1 |
0.814~60 kHz | 614 Vm−1 | 0.1 mT | 81.4 Am−1 |
60~100 kHz | 614 Vm−1 | 6/f mT | 4,880/f Am−1 |
*EF: electric field, †MF: magnetic field
Frequency (f) | EF* | Magnetic flux density | MF† | Power density |
---|---|---|---|---|
0.1~3.0 MHz | 614Vm−1 | 6/f μT | 4.88/f Am−1 | |
3.0~30 MHz | 1,842/f Vm−1 | 6/f μT | 4.88/f Am−1 | |
30~400 MHz | 61.4Vm−1 | 0.2 μT | 0.163Am−1 | 10Wm−2 |
400~2000 MHz | 3.07f0.5Vm−1 | 0.01f0.5 μT | 8.14f0.5mAm−1 | f/40 Wm−2 |
2~300 GHz | 137Vm−1 | 0.447 μT | 0.364Am−1 | 50Wm−2 |
*EF: electric field, †MF: magnetic field
OEL-Ms of time-varying electric fields
OEL-Ms of static and time-varying magnetic fields
Occupational Exposure Limit for ultraviolet radiation with wavelengths between 180 nm and 400 nm is recommended to be 30 J/m2 as effective irradiance integrated over 8 hours a day, to avoid acute effects on eye (cornea or conjunctiva) or the skin. This value is not applicable to laser radiation.
Effective irradiance is defined as follows:
where: Eeff = effective irradiance
Eλ = spectral irradiance at exposure
S (λ) = relative spectral effectiveness (Table XIII)
Δλ = band width
Wavelength (nm) | Relative spectral effectiveness | Wavelength (nm) | Relative spectral effectiveness | Wavelength (nm) | Relative spectral effectiveness |
---|---|---|---|---|---|
180 | 0.012 | 280 | 0.880 | 325 | 0.00050 |
190 | 0.019 | 285 | 0.770 | 328 | 0.00044 |
200 | 0.030 | 290 | 0.640 | 330 | 0.00041 |
205 | 0.051 | 295 | 0.540 | 333 | 0.00037 |
210 | 0.075 | 297 | 0.460 | 335 | 0.00034 |
215 | 0.094 | 300 | 0.300 | 340 | 0.00027 |
220 | 0.120 | 303 | 0.120 | 345 | 0.00023 |
225 | 0.150 | 305 | 0.060 | 350 | 0.00020 |
230 | 0.190 | 308 | 0.025 | 355 | 0.00016 |
235 | 0.230 | 310 | 0.015 | 360 | 0.00013 |
240 | 0.300 | 313 | 0.006 | 365 | 0.00011 |
245 | 0.360 | 315 | 0.003 | 370 | 0.000094 |
250 | 0.430 | 316 | 0.0023 | 375 | 0.000077 |
254 | 0.500 | 317 | 0.0020 | 380 | 0.000064 |
255 | 0.520 | 318 | 0.0016 | 385 | 0.000053 |
260 | 0.650 | 319 | 0.0012 | 390 | 0.000044 |
265 | 0.810 | 320 | 0.0010 | 395 | 0.000036 |
270 | 1.000 | 322 | 0.00067 | 400 | 0.000030 |
275 | 0.970 | 323 | 0.00054 |
Tetsuo Nomiyama (Matsumoto)
MembersKenichi Azuma (Osaka), Tetsuhito Fukushima (Fukushima), Kunio Hara (Kita-Kyusyu), Hajime Hori (Kita-Kyusyu), Seichi Horie (Kita-Kyusyu), Masayoshi Ichiba (Saga), Gaku Ichihara (Chiba), Tatsuya Ishitake (Kurume), Akiyoshi Ito (Kawasaki), Satoko Iwasawa (Tokorozawa), Michihiro Kamijima (Nagoya), Kanae Karita (Tokyo), Takahiko Katoh (Kumamoto), Toshihiro Kawamoto (Tokyo), Shinji Kumagai (Sakai), Yukinori Kusaka (Shimane), Muneyuki Miyagawa (Tokyo), Hiroyuki Miyauchi (Kita-Kyusyu), Yasuo Morimoto (Kita-Kyusyu), Hirokazu Okuda (Kanagawa), Kazuyuki Omae (Tokyo), Tomotaka Sobue (Suita), Toru Takebayashi (Tokyo), Tatsuya Takeshita (Wakayama), Yuko Yamano (Tokyo), Kazuhito Yokoyama (Tokyo)
Drafting membersAtsuko Araki (Sapporo), Kouji Harada (Kyoto), Hyogo Horiguchi (Sagamihara), Yuki Ito (Nagoya), Takeyasu Kakamu (Fukushima), Akiko Matsumoto (Saga), Hisao Naito (Nagoya), Makiko Nakano (Tokyo), Masayuki Okuda (Yamaguchi), Kazuhiro Sato (Fukui), Yasushi Suwazono (Chiba), Akito Takeuchi (Osaka), Ayano Takeuchi (Tokyo), Mayumi Tsuji (Kita-Kyusyu), Teruomi Tsukahara (Matsumoto), Susumu Ueno (Kita-Kyusyu), Jun Ueyama (Nagoya), Yumi Umeda (Kanagawa), Kenya Yamamoto (Kawasaki), Takenori Yamauchi (Tokyo)
Advisory membersGinji Endo (Osaka), Yoko Endo (Osaka), Toshio Kawai (Osaka), Reiko Kishi (Sapporo), Kasuke Nagano (Kanagawa), Tamie Nakajima (Kasugai), Shigeru Tanaka (Saitama), Eiji Yano (Tokyo)